Characterization of a Mouse Model lacking Acetylcholine Receptor Activity during Embryonic Development by Pacifici, Pier Giorgio
  
 
 
 
 
 
INAUGURAL-DISSERTATION 
 
zur 
Erlangung der Doktorwürde 
der 
Naturwissenschaftlich-Mathematischen Gesamtfakultät 
der 
Ruprecht-Karls-Universität 
Heidelberg 
 
 
 
 
 
 
 
 
 
 
 
vorgelegt von 
Diplom-Biologe Pier Giorgio Pacifici 
Tag der mündlichen Prüfung: ................ 
 
 
 
 
 
 
 
 
 
CHARACTERIZATION OF A MOUSE MODEL 
LACKING ACETYLCHOLINE RECEPTOR ACTIVITY 
DURING EMBRYONIC DEVELOPMENT 
 
 
 
 
 
 
 
 
 
 
 
 
 
Gutachter:  Prof. Dr. Christoph Schuster 
  Prof. Dr. Veit Witzemann 
  
 
 
 
 
 
 
 
 
 
 
To my family. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
It is a good morning exercise for a research scientist 
to discard a pet hypothesis every day before breakfast. 
It keeps him young.  
 
- Konrad Lorenz (1903 – 1989) 
4 
 
ACKNOWLEDGEMENTS 
 
 
The work described in this thesis would not have been completed without the support 
and the help provided by many.  
 
I would like to thank Prof. Dr. Veit Witzemann for his invaluable help during the 
course of my doctoral thesis, for his support and his availability to talk and discuss 
issues, as well as for his believing in me and providing an exciting atmosphere where 
to work. Prof. Dr. Christoph Schuster for being my first supervisor and taking an 
interest in my thesis. Dr. Michael Koenen for providing the original γ/ε construct and 
for interesting discussions, as well as Dr. Christoph Peter for the γ/ε-fc mouse line.  
 
A great many thanks for the scientific discussions, support, pleasant and exciting 
working atmosphere, and for a wonderful doctoral period to all the members of the 
lab: Karina Barenhoff, Michaela Bauer, Frédéric Chevessier, Helga Claser, Daniela 
Kolbinger, Ulrike Mersdorf, Leo Schrass (†), Patrick Schweizer and Suse Zobeley. 
Thanks in particular to Pessah Yampolsky for the many insightful scientific 
discussions and speculations.  
 
I would also like to thank Dr. Günther Giese and Annemarie Schebarth for their 
introduction to confocal microscopy and their help with the SP2 microscope.  
 
Furthermore, I wish to thank the members of the Zellphysiologie department and the 
Molekulare Neurobiologie department for providing a friendly work environment, 
Prof. Dr. Bert Sakmann and Prof. Dr. Peter Seeburg for their support, the other PhD 
students for supporting one another, and the helping hands of the Max Planck 
Institute for Medical Research for allowing our work to proceed more easily.  
 
Thanks also to Prof. Dr. Hannah Monyer, Frau Catherine Munzig and Frau Laura 
Winkel for accepting me in the Graduiertenkolleg 791/2 and for providing further 
education possibilities, as well as funding, during my doctoral period. Similarly, I 
would like to thank my PhD colleagues from the GK791 for the enjoyable experience 
and the interesting talks, as well as for the great time together during the retreats 
5 
 
each year. Thanks in particular to Steffen Jährling and Martin Novak for the great 
evenings, Florian Freudenberg for the friendship and Sophie Knobloch for, well, 
being herself.  
 
Even with the support provided by all these people, this thesis would never have been 
completed without my friends – Sandro Altamura, Simone Astori, Anne Charlotte and 
Chris Balduf, Daniele Campa, Davide Cerone, Paolo Del Rocino, Valentina Della 
Gatta, Maria Teresa Di Mascio, Samuele Marro, Paolo Mele, Petra Örsy, Cosmeri 
Rizzato, Gabriele Rizzo, Jakub and Dagmara Swiercz, as well as all those whom I 
may have forgotten to thank here.  
 
My greatest thanks, however, go to my family, who always believed in me and without 
whom I could never have finished. To my grandmother Anna for being here, to my 
grandfather Sante because he would have liked to see this day, to my grandmother 
Velia and my grandfather Sisto whom I also wish were here today. To my relatives 
(especially the little ones) for always being interested in how my thesis was going and 
for always being supportive.  
Most of all to my parents, for their patience, love and understanding (not to mention 
enduring my discussions on how interesting the experiments were, even though they 
would not understand a word), and to my brother Daniele for always being there… in 
his own unique way.  
 
And finally, I would like to thank all those whom I did not mention, but who were very 
helpful during the thesis period. 
 
 
 
 
 
 
 
Heidelberg, 9/11/2008                           Pier Giorgio 
 
6 
 
1. ABSTRACT AND ZUSAMMENFASSUNG 
 
 
1.1     Abstract 
 
During embryonic development, acetylcholine (ACh) and the acetylcholine receptor 
(AChR) play a pivotal role in the establishment, maturation and maintenance of the 
neuromuscular junction (NMJ). In humans, genetic mutations affecting AChR-mediated 
signal transduction give rise to a variety of phenotypes mainly defined by muscle 
weakness, and known as congenital myasthenic syndromes (CMS), demonstrating the 
importance of AChR for the correct development of nerve/muscle contacts. However, thus 
far it has been impossible to determine the specific role played by AChR-mediated 
postsynaptic activity in NMJs during embryonic development. 
In this work, the effects caused by lack of postsynaptic activity in the NMJ were studied 
on a reporter mouse line generated by homologous recombination and expressing a 
structurally intact but functionally silent GFP-tagged AChR. In these animals, the γ 
subunit of the AChR, normally expressed during embryonic development, carries a point 
mutation (P121L) which causes fast-channel CMS in human patients. Homozygous γ/ε-fc 
animals die at birth, and a wide variety of severe physiological abnormalities appears 
during embryonic development, caused by the silencing of AChR-mediated postsynaptic 
potentials. The size, shape and density of the NMJ were profoundly altered by lack of 
postsynaptic activity, although the overall number of receptors did not seem to change. A 
vastly increased outgrowth of motor axons could also be detected, and this alteration is 
associated with the absence of motoneuron death at late embryonic stages. Further 
alterations could be found in the disorganization of muscle fiber architecture, and the 
presence of multiple innervation sites on single muscle fibers. These results clarify the 
role of AChR-mediated postsynaptic activity in the proper development and maturation of 
nerve/muscle contacts, and support the possibility that presynaptic development is 
influenced by putative reciprocal signaling between nerve and muscle. The reporter mice 
provide a new tool to distinguish in an as-yet unknown resolution between activity-
dependent and putative structurally-dependent pathways during NMJ maturation, leading 
to important implications in the study of synapse formation and maintenance, as well as in 
the field of receptor studies.  
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1.2     Zusammenfassung 
 
Während der Embryonalentwicklung, spielen Acetylcholin (ACh) und der 
Acetylcholinrezeptor (AChR) eine entscheidende Rolle bei der Etablierung, Entwicklung 
und Stabilisierung der neuromuskulären Synapse (NMJ). Genetische Mutationen, die die 
AChR-vermittelte Signaltransduktion beeinträchtigen, verursachen in Menschen 
Krankheiten, die vor allem durch Muskelschwäche definiert, und als Congenitale 
Myasthenische Syndrome (CMS) bekannt sind. Dies demonstriert wie wichtig der AChR 
für die korrekte Entwicklung der Nerv/Muskel-Kontakte ist. Allerdings war es bislang 
unmöglich, die spezifische Rolle der AChR-vermittelten postsynaptischen Aktivität in 
NMJ während der Embryonalentwicklung zu bestimmen.  
In dieser Arbeit wurde untersucht, wie sich das Fehlen von postsynaptischen Aktivitäten 
in NMJ auswirkt. Dazu wurde mittels homologer Rekombination eine Reportermauslinie 
generiert, die strukturell intakte aber funktionell stumme mit GFP-markierte AChR 
exprimierte. In diesen Tieren trägt die γ Untereinheit des AChR, die normalerweise 
während der Embryonalentwicklung exprimiert wird, eine Punktmutation (P121L), 
welche „fast-channel“ CMS in Humanpatienten verursacht. Homozygote γ/ε-fc Tiere 
sterben bei der Geburt. Die Analyse zeigt schwerwiegenden, physiologischen 
Abnormalitäten während der Embryonalentwicklung. Die Größe, Form und AChR Dichte 
der NMJ wird durch der Mangel an synaptischer Aktivität tiefgreifend verändert, obwohl 
die Gesamtzahl der Rezeptoren scheinbar unverändert ist. Außerdem ist das Wachstum 
des motorischen Axons stark erhöht und das entwicklungsabhängige Sterben von 
Motorneuronen finden nicht statt. Weitere Veränderungen können hinsichtlich der 
Desorganisation von Muskelfaserarchitektur und der Anwesenheit von multiplen 
Innervierungsstellen an einzelnen Muskelfasern festgestellt werden. Diese Ergebnisse 
verdeutlichen die zentrale Rolle von AChR-vermittelter postsynaptischer Aktivität für die 
korrekte Entwicklung und Reifung der Nerv/Muskel-Kontakte, und deuten darauf hin, 
dass präsynaptische Entwicklung durch ein putatives reziprokes Signal zwischen Nerv 
und Muskel beeinflusst wird. Die Reportermäuse stellen ein neues Werkzeug dar, um in 
bisher unerreichter Auflösung zwischen „aktivitätsabhängigen“ und bzw. 
„strukturabhängigen“ Signalen während der Entwicklung der NMJ zu unterscheiden. Sie 
tragen entscheidend zur Erforschung der Bildung und Stabilisierung von Synapsen und 
der regulatorischen Funktion der Neurotransmitterrezeptoren bei.  
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Na sodium 
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RT- reverse transcription 
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and bearing the P121L 
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4. INTRODUCTION 
 
 
4.1     The Neuromuscular Junction 
 
Animals coordinate cellular activities, process and respond to stimuli through the 
activity of highly specialized nerve cells. Neurons signal to target cells through 
specific sites of contact, called synapses, through the release of different chemicals 
known as neurotransmitters. Target cells are usually other neurons, but they can also 
be endocrine cells or, in the case of motor neurons, skeletal muscle fibers. The 
synapse between a motor neuron and a muscle fiber is called a neuromuscular 
junction (NMJ).  
The NMJ is the best studied chemical synapse in vertebrates, due to a number of 
advantages: NMJs are readily accessible because of their peripheral location, and they 
are over one hundred times larger than the typical brain synapse. Furthermore, NMJs 
are relatively simple, and because each muscle fiber is normally innervated by only 
one nerve terminal, they produce a very simple innervation pattern. Finally, chemical 
signaling at the NMJ involves the opening of a single type of ion channel in the 
postsynaptic membrane. These features make the NMJ an ideal site to study synapse 
development, synapse maintenance and chemical signaling, and to explore the role of 
individual molecules in these processes.  
 
 
4.1.1     Structure of the NMJ 
 
The vertebrate NMJ is a chemical synapse, composed by the presynaptic nerve 
ending, the postsynaptic muscle membrane, called endplate, the basal lamina, and the 
terminal Schwann cell. The axon of the motor neuron innervates the specialized 
endplate region of the muscle fiber, and is separated from the muscle membrane by a 
100 nm synaptic cleft. The number and positioning of the NMJs on a muscle fiber, 
their shape and complexity vary not only from species to species, but also from 
muscle to muscle within individual organisms. In vertebrates, the NMJ responds to 
the neurotransmitter acetylcholine (ACh).  
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The presynaptic nerve ending contains synaptic vesicles filled with ACh, and voltage-
gated Ca2+ channels which allow Ca2+ entry within the nerve terminal with each 
action potential, triggering the fusion of synaptic vesicles to the presynaptic 
membrane, and the release of ACh into the synaptic cleft.  
The endplate muscle membrane is organized into a series of postjunctional folds; 
nicotinic AChRs (AChR) are densely clustered on the crests of these postjunctional 
folds. The membrane within the postjunctional folds is instead rich in voltage-gated 
Nav1.4 channels. The basal lamina is located within the synaptic cleft, and is 
composed of collagen and other extracellular matrix proteins, including 
acetylcholinesterase (AChE) which is anchored to the basal lamina through 
collagenase Q (ColQ) and rapidly hydrolises released ACh.  
 
 
 
Fig. 1: Structure of the NMJ.  
The NMJ is composed of the presynaptic nerve terminal (1), the Schwann cell (2), 
the basal lamina (3) and the postsynaptic endplate (4). ACh (red) is contained within 
synaptic vesicles. The postsynaptic membrane is arranged into postjunctional folds 
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(5) rich in voltage-gated Nav1.4 channels (blue), and whose crests are densely 
packed with AChRs (green). Upon the arrival of an action potential, ACh is released 
into the synaptic cleft and binds to the AChRs, evoking an endplate potential.  
 
 
4.1.2     Activity of the NMJ 
 
Under normal circumstances, the resting potential of a muscle fiber is about -90 mV 
(Fatt and Katz, 1951). When an action potential propagates along the axon and 
reaches the presynaptic nerve terminal, it triggers the opening of voltage-gated Ca2+ 
channels in the neuronal cell membrane, leading to the entry of Ca2+ ions into the 
presynaptic nerve terminal according to the electrochemical gradient. The increase in 
Ca2+ concentration within the presynaptic nerve terminal in turn triggers the fusion of 
synaptic vesicles into the presynaptic nerve membrane, and the release of the ACh 
contained within them into the synaptic cleft. Released ACh freely diffuses into the 
cleft, and binds to the nicotinic AChRs on the postjunctional crests, opening their ion 
channels. The short activation of the AChRs on the postsynaptic membrane 
(approximately a few ms) allows entry of a large number of Na+ ions as well as a 
small number of Ca2+ ions, and to the release of K+ ions, leading to a rapid 
depolarization. This excitatory postsynaptic potential is called the endplate potential 
(EPP).  The electrical current generated by the channel opening event is called 
endplate current (EPC) (Fatt and Katz, 1951). 
If the endplate potential reaches threshold voltage (approximately -50 mV), it triggers 
the activation of voltage-gated Nav1.4 channels in the postjunctional folds, converting 
the endplate potential into an action potential that propagates in both directions along 
the muscle fiber, causing its contraction. In the meantime, the concentration of ACh 
in the synaptic cleft is quickly reduced due to diffusion outside the cleft and to rapid 
hydrolysis on the part of the enzyme acetylcholinesterase into acetate and choline. 
This leads to the deactivation of AChRs, and to the repolarization of the muscle fiber 
in the absence of further stimuli. Choline is then reabsorbed by the nerve terminal and 
recycled into new molecules of ACh through the action of choline acetyltransferase 
(ChAT). AChRs on the postsynaptic muscle membrane therefore play a critical role 
in the correct functioning of the NMJ.  
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4.2     The Acetylcholine Receptor 
 
4.2.1     Structure of the Acetylcholine Receptor 
 
The muscle-specific nicotinic AChR is a glycoproteic pentameric ligand-gated ion 
channel (Raftery et al., 1980), located in the crests of the postjunctional folds of the 
NMJ (Sanes and Lichtman, 2001). It is composed of two α subunits, one β subunit, 
one δ subunit, and either a γ subunit during embryonic development (AChRγ) or an ε 
subunit in mature synapses (AChRε) (Mishina et al., 1986). 
Each subunit contains between 450 to 520 amino acids, with a long N-terminal 
extracellular region, four transmembrane domains (labeled M1 to M4), a large 
cytoplasmic loop between M3 and M4 (Karlin and Akabas, 1995), and a short C-
terminal extracellular region. The M2 transmembrane domain of each subunit forms 
the channel pore of the AChR and is responsible for cation selectivity (Imoto et al., 
1988; Miyazawa et al., 1999; Miyazawa et al., 2003), while the cytoplasmic loop is 
involved in the clustering of receptors in the NMJ (Maimone and Enigk, 1999).  
 
   
 
 
Fig. 2: Structure of the AChR.  
(A) Schematic drawing of the structure of an AChR subunit. Each subunit contains 
four transmembrane domains (M1 to M4), a long N-terminal region, and a large 
cytoplasmic loop between transmembrane domains M3 and M4, which plays a role 
in the aggregation of subunits. (B) Schematic drawing of the complete pentameric 
AChR receptor. Each subunit (large circles) is drawn along with the arrangement of 
A                                                                 B 
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the four transmembrane domains (small white circles). The two ACh binding sites, 
located between the α and δ subunit, and the α and γ (or ε) subunit are shown as 
dark circles. The M2 transmembrane domains of the five subunits make up the inner 
surface of the ion channel. 
 
The AChR is present in the adult NMJ with a density of about 104 AChRs per μm2, 
concentrated on the postjunctional crests, whereas its density in the rest of the muscle 
fiber is 10 molecules per μm2 (Colledge and Froehner, 1998). This heterogeneity is 
established during the embryonic development of the NMJ.  
 
 
4.3     Development of the NMJ 
 
4.3.1     Embryonic Development of the Muscle 
 
Myoblasts are generated from the somites of the embryonic paraxial mesoderm, 
located on both sides of the neural tube and the notochord. These cells migrate 
together and fuse into syncytia, forming myotubes which eventually grow into 
skeletal muscle fibers.  
 
 
4.3.2     Prenatal Nerve-Muscle Interactions 
 
Further development of the myotubes occurs through muscle-specific gene 
transcription under the control of myogenic differentiation factors (MDFs). Among 
them are the members of the “basic helix-loop-helix” protein family, such as MyoD, 
myogenin, myf5 and MRF4. In their activated form, MDFs dimerize with the so-
called E-proteins and bind to specific promoter elements, the E-box (CANNTG 
consensus sequence). Since E-box promoter elements are prevalently found in 
muscle-specific genes, the binding of MDFs increases transcriptional activity for 
these genes in the context of myogenic differentiation (Lassar et al., 1991). 
The establishment of synaptic contact between nerve and muscle cells occurs after the 
beginning of myotube development; this leads to further differentiation of the two cell 
types through coordinated neuromuscular interaction (Witzemann, 2006).  
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Investigations of the relationship between innervation and control of gene 
transcription identified neural factors influencing the expression of structural proteins 
and receptors in muscle cells (McMahan, 1990; Misgeld et al., 2002). Similarly, 
putative retrograde muscle-derived signals capable of affecting the differentiation of 
the presynaptic nerve were reported (Caroni, 1993; Godfrey and Schwarte, 2003). 
Signal transmission, which initiates and modulates these processes, can be found 
almost exclusively in the vicinity of the NMJ.  
It is not yet clear how the differentiation of pre- and postsynaptic elements might be 
coordinated, and how precise patterning and location of synaptic activity might be 
achieved. Glial cells in the immediate vicinity of the synapse might provide 
additional signals (Goda and Davis, 2003).  
During prenatal development, the NMJ undergoes far-reaching changes. The AChRs 
form clusters in key areas of skeletal muscle fibers, which will later differentiate into 
functioning NMJ; subsynaptic nuclei increase the transcription levels of AChR 
subunits, and the muscle fiber membrane forms characteristic postjunctional folds. 
Synaptic contacts are established and, later, partially eliminated. Uninnervated 
clusters disgregate.  
 
 
4.3.3     The γ / ε Subunit Switch 
 
During embryonic development, fetal-type AChRs are assembled from two α 
subunits, one β subunit, one δ subunit and one γ subunit. The composition of the 
receptor, however, changes during perinatal development, when the fetal γ subunit is 
replaced by the adult-type ε subunit (Sakmann and Brenner, 1978; Witzemann et al., 
1987; Witzemann et al., 1989; Witzemann et al., 1991; Kues et al., 1995a; Kues et al., 
1995b).  
The subunit switch leads to a change in the electrophysiological properties of the 
AChR (Mishina et al., 1986), such as conductivity, permeability to Ca2+ ions, and 
channel opening times (Villarroel and Sakmann, 1996). In mice, the γ/ε subunit 
switch occurs within the first week after birth.  
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4.3.4     Pre-patterning of the NMJ 
 
In the diaphragm muscle, NMJs are normally localized in the center of the muscle 
fibers, forming a region known as the synaptic band. This highly ordered organization 
of NMJs is formed during embryogenesis through a process known as pre-patterning, 
in which small aggregates of AChRs form in the muscle membrane. The process is 
continued and stabilized by the nerve terminal through the action of nerve-derived 
factors (Yang et al., 2001). The fetal subunit of the AChR plays a role in the proper 
distribution of these aggregates as well. The molecular mechanisms of synaptic band 
positioning are not yet well understood. 
 
 
4.3.5     The Agrin Signal Cascade 
 
Several nerve-derived factors have been shown to play a role in the further 
differentiation of the postsynaptic muscle fiber, in the stabilization of AChR 
aggregates, and in the development of a mature NMJ. In vivo and in vitro studies have 
identified several components of the molecular machinery driving this process, and 
their functions in the developing NMJ (Sanes and Lichtman, 2001). With the increase 
in the number of transgenic mouse lines and the development of conditional knock-
out lines, the model for the embryonic development of the NMJ has recently 
undergone several changes (Kummer et al., 2006).  
The current model, which is primarily based on studies of transgenic mouse lines, 
describes the nerve-independent formation of small clusters of AChRs which are 
attracted and incorporated in the nascent synapse (Flanagan-Steet et al., 2005), and 
which in turn stabilize nerve-muscle interactions, and attract new filopodia towards 
the contacted region. Further AChR clustering requires the action of agrin (McMahan 
et al., 1990; Gautam et al., 1996), a large heparin sulphate proteoglycan whose nerve-
derived isoform, called z+ agrin, has been demonstrated to function as an aggregation 
factor for AChRs (McMahan, 1990; Burgess et al., 1999). Z+ agrin is transported 
down motor neurons and released from the nerve terminal, where it stably associates 
with the basal lamina of the synaptic cleft.  
Secretion of z+ agrin on the part of the nerve terminal activates a muscle-specific 
transmembrane receptor tyrosine kinase called MuSK (DeChiara et al., 1996; Glass et 
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al., 1996). Because no experiments have yet conclusively proved direct binding of 
agrin to MuSK, it is currently suggested that z+ agrin interacts with MuSK through 
the low-density lipoprotein receptor protein, Lrp4 (Kim et al., 2008; Zhang et al., 
2008), which is believed to form dimers or oligomers in the absence of agrin and 
associates with MuSK. Once activated, Lrp4-MuSK complexes are reorganized, 
MuSK is dimerized and phosphorylates itself; the newly discovered protein Dok7 has 
been suggested to play a role in the self-phosphorylation of MuSK (Okada et al., 
2006). In vitro experiments have shown that z+ agrin – MuSK  interaction can 
activate tyrosine kinases of the SRC family, such as cdc42, Rac and PAK (Weston et 
al., 2000; Luo et al., 2002). The activation of these kinases in turn phosphorylates the 
β subunit of the AChRγ. (Mohamed et al., 2001). 
 
 
Fig. 3: Possible Signal Cascade involved in AChR Clustering.  
Schematic drawing of the possible signal cascade involved in AChR clustering 
during embryonic development. The motor axon secretes z+ agrin, which interacts 
with MuSK through a receptor protein (Lrp4). MuSK-Lrp4 complexes are 
reorganized and MuSK dimers interact with kinase Dok7, leading to MuSK self-
phosphorylation, which activates SRC-family kinases such as PAK, Rac and Cdc42. 
These kinases phosphorylate the β subunit of the AChR, possibly leading to docking 
of the receptor to the β unit of the dystroglycan complex (DG) through the action of 
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rapsyn (Gautam et al., 1995). The dystroglycan complex is bound to utrophin, which 
tethers it to the actin cytoskeleton.  
 
Clustering of the AChRs requires the presence of rapsyn, a 43-kDA membrane-
associated cytoplasmic protein which is equimolar with the AChR, and is tightly 
associated with it (Noakes et al., 1993; LaRochelle et al., 1986); in vivo and in vitro 
studies have demonstrated that in the absence of rapsyn, no AChR clustering can 
occur (Gautam et al., 1995).  
Rapsyn might tether the AChR to the actin cytoskeleton through dystroglycan, 
playing an important role in receptor clustering. However, although rapsyn in non-
muscle cells can cluster in response to agrin with or without AChRs, absence of 
AChRs in muscle cells prevents clustering of rapsyn, showing that AChRs contribute 
actively to the clustering process (Grow and Gordon, 2000; Missias et al., 1997). In 
fact, AChR-mediated activity leads to the inhibition of AChR transcription in extra-
synaptic nuclei, and to the transcriptional specialization of subsynaptic nuclei.  
In vivo studies on knock-out mice have further elucidated aspects of the signal 
cascade. Among other things, the discovery of AChR clusters in agrin-deficient or 
aneural muscles (Gautam et al., 1996; Yang et al., 2001), as well as the 
characterization of agrin- and AChR-deficient double KO mice (Misgeld et al., 2005), 
demonstrated that agrin counteracts the dispersal effect of a second nerve-derived 
factor; in vitro experiments have identified ACh as a dispersal factor. Although the 
mechanism remains unclear, it is known to require kinase Cdk5, and to presumably 
involve endocytosis (Lin et al., 2005).  
 
 
4.3.6     Regulation of Transcription of AChR Subunits 
 
Under the current paradigm of NMJ formation, little is known about the regulation of 
transcription of the various AChR subunits. While it was once thought that 
neuregulin, a nerve-derived factor, stimulated subsynaptic nucleus specialization and 
the synthesis of AChRs, studies of transgenic mouse lines have painted a more 
complicated picture. While neuregulin might have a modulatory role in regards to the 
synthesis of AChR subunits, AChRs are synthetized even in its absence (Escher et al., 
2005). Furthermore, transcriptional specialization has been demonstrated to occur 
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even in the absence of innervation (Lin et al., 2001; Yang et al., 2001), although its 
maintenance appears to require both agrin and MuSK (DeChiara et al., 1996; Lin et 
al., 2000; Escher et al, 2005). The ETS transcription factor Erm, whose expression is 
limited to subsynaptic nuclei, has also been shown through transgenic mouse models 
to play a role as an upstream regulator of a transcriptional program which includes 
genes for several postsynaptic proteins, such as MuSK and the ε subunit of the AChR 
receptor (Hippenmeyer et al., 2007). Although other molecules have been implicated 
in the process, the exact mechanisms of transcription regulation of the AChRs is still 
unclear.  
 
 
4.3.7     Differentiation of Motor Axons 
 
Innervating axons undergo several changes during the development of the NMJ. 
Axons innervate muscle fibers at the synaptic band, and then halt their growth; it is 
speculated that a yet unknown retrograde signal from muscle to nerve may be 
implicated in the process. In embryonic development, each endplate is innervated by 
several axons; during perinatal and early postnatal development, each neuromuscular 
synapse undergoes elimination of the majority of its innervating axons, until each 
NMJ is innervated by only one axon. The mechanism by which this selection occurs 
is still unclear, although activity has been proposed as one of the factors involved 
(Wyatt and Balice-Gordon, 2003). In the meantime, the surviving axon also 
undergoes further development, and its nerve terminal is enriched with ACh vesicles, 
which can be released in response to an action potential. 
 
 
4.3.8     Maturation of the NMJ 
 
The NMJ undergoes maturation during the perinatal and early postnatal period, in 
conjunction with the onset of the γ/ε switch (4.3.3). The NMJ dramatically increases 
in size, and changes shape from ovoid to a more elaborate, “pretzel-like” structure. At 
the same time, postjunctional folds become more prominent, increasing the overall 
area of the synapse, until the NMJ reaches its adult configuration (Marques et al., 
2000). During this process, AChRs cluster on the postjunctional crests, the closest 
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position to the presynaptic terminal, while the Nav1.4 channels accumulate at the 
bottom of the postjunctional folds (Figure 2). Although little is known about the 
mechanisms that drive NMJ maturation, in vitro studies have demonstrated that 
cultured myotubes can form complex structures, very similar to mature NMJs, even in 
absence of innervation (Kummer et al., 2004). However, it is still unknown how 
muscle-derived and nerve-derived factors may interact to produce a mature endplate 
in vivo. 
 
 
4.4     Congenital Myasthenic Syndromes 
 
Inherited defects in genes involved in the development and maintenance of the NMJ 
produce a heterogeneous group of disorders collectively known as congenital 
myasthenic syndromes (CMSs), associated with abnormal muscle weakness and 
fatigability on exertion (Engel et al., 2003a). The genetic defects involved in CMSs 
may impair neuromuscular transmission either directly, or by causing alterations of 
the NMJ structure which eventually compromise its safety margin.  
Different types of CMSs are caused by mutations in different genes, or sometimes in 
different exons of the same gene (Table 1).  
 
Table 1. Classification of congenital myasthenic syndromes 
 
Presynaptic defects 
 ChAT deficiency 
 Paucity of synaptic vesicles/reduced quantal release 
 
Synaptic – Basal lamina-associated defects 
 Endplate AChE deficiency 
  AChE deficiency 
  ColQ deficiency 
 
Postsynaptic defects 
 Kinetic abnormalities of AChR (with or without AChR deficiency) 
  Slow-channel syndrome 
  Fast-channel syndrome 
  High-conductance fast channel syndrome 
Impaired AChR clustering 
Rapsyn deficiency 
MuSK deficiency 
Dok7 deficiency 
Kinetic defects in Nav1.4 
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Mutations involving choline acetyltransferase (ChAT), acetylcholinesterase (AChE), 
rapsyn, ColQ (a form of collagenase tethering AChE to the basal lamina) or subunits 
of the AChRs have all been identified in CMS patients (Müller et al., 2007). The 
current CMS classification is based on the recognized site of the defect, i.e. 
presynaptic, synaptic or postsynaptic. 
The diagnosis of congenital myasthenic syndromes is based on the presence of 
myasthenic symptoms since birth or early childhood, such as a high-arched palate, 
weakness in the ocular muscles, cranial muscles and/or limbs, a history of similarly 
affected relatives, and abnormal electromyographic measurements. They may also 
include respiratory symptoms, delayed motor milestones, and negative tests for AChR 
antibodies (Engel and Franzini-Armstrong, 1994). Although many different types of 
CMSs have been identified and classified, the causes behind others remain elusive.  
Most of the genetic defects associated with CMSs are caused by recessive, loss-of-
function mutations, except for slow-channel syndrome which is associated with a 
dominant gain-of-function mutation (Engel et al., 2003b). 
Congenital myasthenic syndrome mutations have been identified in various domains 
of all AChR subunits; depending on their effect, they produce kinetic abnormalities 
which can be grouped into two categories: slow-channel and fast-channel syndromes 
(Table 2).  
 
Table 2. Kinetic abnormalities of AChR (adapted from Engel et al., 2003b) 
 
    Slow-channel   Fast-channel 
Endplate currents  Slow decay   Fast decay 
Channel-opening events  Prolonged   Brief 
Open states   Stabilized   Destabilized 
Closed states   Destabilized   Stabilized 
Mechanisms   Increased affinity  Decreased affinity 
    Increased β   Decreased β 
    Decreased α   Increased α 
Pathology   Endplate myopathy  No anatomic footprint 
Genetic Background  Dominant gain-of-function Recessive loss-of-function 
 
Abbreviations: β, channel-opening rate; α, channel-closing rate. 
 
 
 
26 
 
4.4.1     Fast-Channel Congenital Myasthenic Syndrome 
 
Fast-channel congenital myasthenic syndromes (FCCMS) are characterized by an 
abnormally short channel-opening time, giving rise to a fast decay of the synaptic 
response. Depending on the mutation, AChR expression might or might not be 
reduced, quantal release by nerve impulse remains normal, but very small MEPPs are 
observed (Uchitel et al., 1993). Mutations giving rise to fast-channel congenital 
myasthenic syndrome have been identified in subunits α, δ and ε of the AChR (Wang 
et al., 1999; Brownlow et al., 2001; Ohno et al., 1996), which form the ligand binding 
sites for ACh (Fig. 2). Depending on their location in the protein sequence, these 
mutations impair normal AChR function in different ways (Fig. 4) 
. 
 
 
Fig. 4: Mutations Involved in Fast-Channel Congenital Myasthenic Syndromes. 
Fast-channel congenital myasthenic syndromes can be caused by mutations in the 
α, δ and ε subunit. Mutations in the extracellular domain diminish receptor affinity 
for ACh; mutations in the transmembrane domains impair gating efficiency; 
mutations in the long cytoplasmic loop affect channel kinetics. Genetic defects 
producing FCCMS are recessive, loss-of-function mutations.  
 
Common to all fast-channel congenital myasthenic syndromes is reduced 
postsynaptic activity in response to ACh, due to reduced probability of channel-
opening events. However, mutations in different loci produce this effect in different 
ways. In the case of mutations located in the extracellular domain, this effect is due to 
a dramatic decrease in frequency and duration of bursts of ACh-induced openings 
(Ohno et al., 1996; Wang et al., 1999). Mutations in the cytoplasmic loop disrupt the 
normal kinetics of the receptor, either causing switches in gating from efficient to 
α                                   δ                                  ε 
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inefficient within individual activation episodes, or producing a broad range of open 
probabilities (Milone et al., 1998; Wang et al., 2000). Therapy in humans involves the 
use of 3,4-diaminopyridine and pyridostigmine, a potassium channel blocker and an 
acetylcholinesterase inhibitor, respectively (Engel et al., 2003b; Parr and Jayawant, 
2007), to increase the concentration of ACh in the synaptic cleft and increase the 
probability of channel-opening events. 
 
 
4.5     Transgenic Mouse Models 
 
The creation of transgenic mouse models is a powerful tool to analyze the specific 
functions of individual molecules in an in vivo model, as well as to mimic human-
specific pathologies.  
Classical transgenic mouse models can be created by pronucleus injection (Gordon et 
al., 1980) or homologous recombination. The latter method, developed thanks to 
technological advances in stem cell culture, has several advantages over pronucleus 
injection, and is currently regarded as the method of choice for the creation of 
classical transgenic mouse lines (Evans and Kaufman, 1981; Capecchi, 1989; 
Thompson et al., 1989). 
Embryonic stem cells from early embryos are genetically altered through in vitro 
homologous recombination, and injected into blastocysts which are implanted into 
pseudopregnant animals, producing chimeric offspring. Breeding chimeric offspring 
expressing the mutation in their germinal cell lines eventually leads to the production 
of a stable transgenic mouse line.  
Homologous recombination is a flexible method which allows both deletion of 
existing genetic material (knock-out) or its replacement with artificial genetic 
material (knock-in). Reporter genes can also be added in order to label cells 
expressing the mutation.  
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5. OBJECTIVES 
 
 
5.1     Overview 
 
Despite the fact that the NMJ has been considered for many years as the main model 
system for synaptogenesis, many questions still remain unanswered, and the 
mechanisms which regulate nerve-muscle contacts, synapse development and 
differentiation are still not fully known. The development of transgenic mouse models 
in the last few years has allowed us to discover the answers to some of these 
questions, offering new insights into the roles of various molecules involved in 
synaptic development and maturation, and forcing us to re-evaluate the previously 
established paradigm describing neuromuscular synapse formation (Kummer et al., 
2006; Witzemann, 2006).  
The role played by the AChR during the formation, development and maturation of 
the NMJ cannot be underestimated. The activity of MuSK, rapsyn and possibly Dok7 
leads to the clustering and pre-patterning of the receptors in skeletal muscle fibers, 
even in the absence of nerve terminals or nerve-derived factors (Yang et al., 2001). 
Agrin stabilizes nerve-muscle contacts and contributes to the further development of 
the nascent NMJ (McMahan et al., 1992). But the analysis of transgenic mouse lines 
reveals that when the presence or functionality of the AChR is compromised (Misgeld 
et al., 2005; Brandon et al., 2003; Heeroma et al., 2003), or when motor neurons fail 
to innervate skeletal muscle fibers (Yang et al., 2001; Lin et al., 2001), further NMJ 
development is impaired and no functional synapses form, implying that both the 
release of ACh from the nerve terminal, and the activity of the AChR play a 
fundamental part in the development of the NMJ. Even so, the retrograde mechanisms 
through which synaptic activity regulates its own further maturation are still 
unknown. Previous studies aimed at analyzing the role of AChR in the development 
of the NMJ using knock-out mouse lines, however, could not differentiate between 
effects caused by disruption of AChR functionality alone, and effects caused by the 
absence of the AChR receptor as a whole.  
Previous work in our lab included the generation of a knock-in mouse model 
expressing structurally intact but functionally silent AChR during embryonic 
development (Peter et al., 2005; Koenen et al., 2005). The goal of this thesis is to 
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characterize this mouse line, analyzing in detail the consequences caused by lack of 
AChR activity during the embryonic development and differentiation of the NMJ, and 
identifying the resulting morphological changes. 
 
 
5.1.1     The γ/ε-fc Mouse Model 
 
Two different forms of AChR play a role in the development and maturation of the 
NMJ (Mishina et al., 1986). The physiological reason for the presence of two 
different types of AChR is still unclear, but it is known that they have different 
electrophysiological properties, and that activity of the AChR is a critical factor 
during the development of the NMJ: it has been shown that transgenic mice lacking 
expression of the fetal γ subunit die shortly after birth (Takahashi et al., 2002), while 
transgenic animals in which expression of the γ subunit has been replaced by 
expression of the adult-type ε subunit during embryonic development show no 
obvious phenotype, and minor morphological changes (Koenen et al., 2005). 
A mouse model generated in our lab permits the study of the effects of AChR activity 
reduction during embryonic development in vivo: while the overall structure of the 
AChR in these mice remains intact, a point mutation originally found in patients 
suffering from a fast-channel congenital myasthenic syndrome was inserted in a 
hybrid γ/ε subunit, drastically reducing the affinity of the receptor for ACh. The 
choice of inserting the mutation into a hybrid subunit, as opposed to the wild-type γ 
subunit, was made following the results of electrophysiological studies performed in 
Xenopus laevis oocytes (Peter et al., 2005), ensuring that receptor activity would be 
almost entirely silenced. Using this model, this thesis aims to answer questions such 
as, what effects are specifically caused by lack of receptor activity during embryonic 
development? Which molecular mechanisms are affected by the silencing of fetal-
type AChRs, and what physiological changes do they lead to? What is the minimum 
level of activity which ensures functionality of the junction, or in other words how 
much redundancy is present in wild-type NMJs? 
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6. RESULTS 
 
 
6.1     The γ/ε-fc Mouse Line 
 
In 1996, a point mutation was identified in the ε subunit of patients suffering from a 
type of postsynaptic congenital myasthenic syndrome (Ohno et al., 1996). The 
mutation replaced the proline located in position 121 with a leucine (εP121L). 
Previous work in our lab used this mutation as the basis to generate a mouse line 
expressing a modified γ subunit with highly reduced activity (Peter C., dissertation 
2003), in order to study the effects caused by lack of activity during the development 
of the neuromuscular junction.  
 
 
6.1.1     Generation of the γ/ε-fc Mouse Line 
 
Because the P121L mutation had maximum effect when expressed in the ε subunit as 
compared to the γ subunit (Peter et al., 2005), the targeting strategy used a γ/ε fusion 
gene, in which ε cDNA replaces the wild-type γ sequence from exon 4 onwards. The 
original vector, γ/ε-p1002, was generated and graciously offered by Dr. Michael 
Koenen. It also contained a GFP cDNA sequence inserted between the 
transmembrane domains M3 and M4, in the long cytoplasmatic loop of the ε cDNA. 
The P121L point mutation was inserted in the ε cDNA using modified primers (Fig. 
5A-C). 
The functional properties of the channel were tested by injecting γ/ε-fc cRNA in 
Xenopus laevis oocytes (Peter et al., 2005). Homologous recombination was 
confirmed through PCR and Southern Blot after ES cell transfection (Fig. 5D-E) 
(Peter C., dissertation 2003). The mRNA expression in muscle cells was verified 
through RT-PCR on muscles of WT and homozygous animals (Fig. 5F-G).  
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Fig. 5: Generation and Structure of the γ/ε - fc Gene.  
(A) Diagram of the wild-type γ subunit. Exons 1 to 12 are represented by red boxes. 
The scheme also shows the position of HindIII restriction sites used to produce the 
A 
 
 
 
 
B 
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4,1 Kb-long fragment for Southern blot analysis. (B) Schematic representation of the 
targeting vector γ/εP121L-GFP-p1002. The purple boxes represent the pBKS vector. 
The ε cDNA (blue box) was inserted in the genomic cDNA sequence using the XbaI 
restriction enzyme. The cDNA contained the P121L mutation, the stop codon and 
the polyA sequence. The PGK Neo selection cassette is represented by a yellow box 
and flanked by two loxP sequences. (C) Schematic representation of the mutated 
γ/ε gene, obtained through homologous recombination. The fragment located 
between the HindIII restriction sites, used for Southern blot analysis, is 6,3 Kb long. 
The fragment was analyzed using synthetized Probe 7 (in red). The fragment used 
for PCR analysis of homologous recombination is 1,4 Kb long. (D) PCR analysis of 
genomic ES cell DNA. Lane 1: PCR analysis of recombined ES cells; Lane 2: PCR 
analysis of wild-type ES cells. (E) Southern Blot of wild-type mouse (lane 4), 
positive ES cell clone (lane 5), heterozygous mouse (lane 6) and homozygous animal 
(lane 7). The wild type γ subunit is represented by a 4,2 Kb fragment while the γ/ε-fc 
subunit is represented by a 6,1 Kb fragment. (F) RT-PCR on muscle cDNA using a g 
subunit-specific primer (mg F 187, mg R 536). The 350 bp fragment is present only 
in muscles of WT animals. (G) RT-PCR on muscle cDNA using a γ/ε subunit-
specific primer (g/e 241 for, mg/e 555 rev). The 315 bp DNA fragment is present 
only in the muscles of homozygous γ/ε-fc animals (M: λ/EcoRI, HindIII marker). 
 
 
6.1.2     Expression of the γ/ε-fc Subunit in the Endplate  
 
The correct expression and localization of the γ/ε-fc subunit can be verified thanks to 
the GFP sequence integrated in the transgene. Diaphragm muscles of homozygous 
mice showing GFP fluorescence were stained with rhodamine-labeled bungarotoxin 
(Rh-bgtx) and analyzed by confocal microscopy (Fig. 6). 
The results showed that the green fluorescence produced by the integrated GFP co-
localized with Rh-bgtx staining the endplate AChRs. Green fluorescence was absent 
in the wild type, as expected. The presence of GFP fluorescence in the endplate of the 
γ/ε-fc animals also confirmed that the γ/ε-fc subunit is assembled into the AChRγ 
complexes that were concentrated at the specific “endplate-like” sites in the 
developing muscle fibers. 
 
 
33 
 
 
. 
Fig. 6: Expression of GFP-tagged γ/ε-fc in a Diaphragm Endplate of E18 
Embryos.  
 (A) confocal image of the endplate of a γ/ε-fc homozygous mouse shows GFP 
fluorescence, which is absent in the endplate of a WT animal; (B) Rh-bgtx staining 
of the γ/ε-fc and WT endplates. (C) Merged image showing the co-localization of 
GFP and the Rh-bgtx staining in the γ/ε-fc endplate, and the lack of green 
fluorescence in the WT endplate. Scale bar: 10 μm. 
 
 
6.2     General Anatomy  
 
6.2.1     Phenotype of the γ/ε-fc Heterozygous Mice  
 
Heterozygous γ/ε-fc mice are viable, showing no differences in phenotype when 
compared to wild-type littermates. Males and females develop normally, are fertile, 
and their lifespan is not affected by the presence of one γ/ε-fc allele.  
 
 
 
 
 
 A         GFP             B       Rh-bgtx             C          Merge 
γ/ε-fc hom 
WT 
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6.2.2     Phenotype of the γ/ε-fc Homozygous Mice  
 
Homozygous γ/ε-fc mice display no movement and no muscle tension during 
embryonic development, and they die at birth, presumably from respiratory failure. 
Differences in appearance can be consistently identified between γ/ε-fc homozygous 
mice and their wild-type littermates (Fig. 7), although their severity varies in different 
embryos even within the same litter. 
Differences in phenotype in γ/ε-fc embryos include the presence of a subcutaneous 
cavity on the dorsal side of the animal, most prominently between the head and the 
upper half of the embryo’s torso, lack of muscle tension, as well as seemingly 
atrophied limbs, a curled-up posture, and lack of movement. Embryos may display 
skin color abnormalities as well. 
 
Fig. 7: Phenotypic Differences between Wild Type and Homozygous Embryos.  
(A, B) Wild type (A) and homozygous (B) E14 embryos. The γ/ε-fc embryo displays 
a slight limb atrophy, and a very prominent subcutaneous cavity on the dorsal side, 
especially noticeable between the head and the upper half of the torso. (C, D) Wild 
type (C) and homozygous (D) E18 embryos. Differences in phenotype include 
abnormal skin pigmentation of the homozygous animal, as well as limb atrophy, 
A                          B            
C                           D          
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curled-up posture, smaller size, lack of muscle tension and movement. The 
subcutaneous cavity is still present, although it is reduced in size.  
 
 
6.2.3     Diaphragm 
 
The diaphragm muscle is a good model to analyze the morphological phenotype of 
γ/ε-fc mutants (Greer et al., 1999). Its relative simplicity, the orderly distribution of 
endplates along the central endplate band, and the innervation pattern which involves 
only the phrenic nerve (and not a mixed population of motoneurons), as well as the 
ease of accessibility and analysis, contribute to the advantages offered by this muscle.  
 
 
 
Fig. 8: Anatomy of the Diaphragm.  
(A) Innervation pattern of the wild type mouse diaphragm muscle (age E18). Top: 
sternum; bottom: lumbar area. The red arrow represents where the phrenic nerve 
enters the left hemidiaphragm. Branches departing from the phrenic nerve innervate 
 A 
 B 
36 
 
the NMJs located in the central endplate band (not shown). (B) Localization of four 
different anatomical sectors in the mouse diaphragm muscle. S1: left lumbar area; 
S2: left sternal area; S3: right sternal area; S4: right lumbar area. The location where 
the phrenic nerve enters and exits the diaphragm (on the left and right 
hemidiaphragm, respectively) is treated as the border between lumbar and sternal 
sectors.  
 
The diaphragm muscle is innervated by the left phrenic nerve, and can be divided into 
two morphologically different hemidiaphragms according to muscle fiber innervation 
pattern (Fig. 8A). Furthermore, because the phrenic nerve splits into two main 
branches upon entering the diaphragm, we decided to further increase the level of 
detail in our analysis by dividing the left and right hemidiaphragms into lumbar and 
sternal regions as well (Fig. 8B).  
 
 
6.3     Anatomy of the NMJ 
 
 
6.3.1     AChR Clusters 
 
The receptor density in NMJs of wild-type and homozygous γ/ε-fc animals aged E16 
and E18 was analyzed through confocal microscopy, in order to study whether 
clustering of the AChRs and endplate formation were significantly affected by the 
reduction of AChR activity. In order to magnify the GFP fluorescence of γ/ε-fc 
subunits, AChRs were stained with FITC- or Alexa488-labeled α-bgtx. 
Fig. 9A and C are confocal images taken from an E16 WT embryo, while Fig. 9B and 
D are confocal images taken from E16 homozygous γ/ε-fc embryo. AChRs cluster 
both in the WT and the homozygous embryo, however, endplates present a round 
shape in WT embryos and a more elongated, irregular shape in the γ/ε-fc. Close-up 
images (Fig. 9C, 9D) reveal slight morphological differences between WT and 
homozygous endplates: the shape of γ/ε-fc endplates is irregular in comparison to that 
of WT endplates, and receptors appear to be clustered unevenly along the surface of 
the endplate, creating areas within the endplate where no receptor fluorescence can be 
detected. 
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At E18, differences in size and shape appeared even more pronounced; endplates in 
the g/e-fc embryo are much larger and irregularly shaped than WT endplates, and 
AChRs are abnormally clustered within discrete punctae in the endplate area, giving 
the endplate a distinct, speckled appearance.  Fig. 10A and C are images taken from an 
E18 WT embryo, while Fig. 10B and D are images taken from an E18 γ/ε-fc embryo. 
Endplates persist in both animals, but the structure of γ/ε-fc endplates appears altered 
in comparison to WT (Fig. 10C, 10D). 
 
 
 
Fig. 9: Bungarotoxin Staining of Diaphragm Endplates from E16 Embryos.  
(A) Overview of endplate distribution in the E16 WT diaphragm. Endplates are 
patterned in the central region of muscle fibers, forming a characteristic central 
endplate band along the diaphragm. (B) Overview of endplate distribution in the E16 
γ/ε-fc diaphragm. Endplates are not concentrated in the central region of muscle 
fibers, but they are patterned randomly across the whole diaphragm. (C) and (D) 
Close-ups of endplates from an E16 WT and γ/ε-fc diaphragm, respectively. 
Individual endplates in the γ/ε-fc embryo are irregularly shaped in comparison to the 
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round WT endplates, and their loss of prepatterning is clearly visible. Both WT and 
γ/ε-fc AChRs are stained with FITC-labeled α-bungarotoxin. Scale bars = 25 μm. 
 
 
 
 
Fig. 10: Bungarotoxin Staining of Diaphragm Endplates from E18 Embryos.  
 (A) Overview of endplate distribution in the E18 WT diaphragm. Endplates 
clustered in the central muscle region (see Fig. 9A). (B) Overview of endplate 
distribution in the E18 γ/ε-fc diaphragm. Endplates, scattered across the diaphragm 
(see Fig. 9B). (C) and (D) Close-ups of endplates from an E18 WT and γ/ε-fc 
diaphragm, respectively. Endplate appearance shows morphological differences 
between the WT and γ/ε-fc animal; WT endplates display a homogeneous round 
shape, whereas γ/ε-fc endplates display a more heterogeneous, speckled appearance. 
Both WT and γ/ε-fc AChRs are stained with FITC-labeled α-bungarotoxin. Scale 
bars = 25 μm. 
 
The different morphology of E16 and E18 endplates from WT and γ/ε-fc embryos is 
exemplified in Fig. 11A. The density of AChRs in E16 and E18 endplates was 
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quantitatively evaluated by measuring fluorescence intensities from different regions 
of the WT and γ/ε-fc diaphragms (Fig. 11B). The average receptor density in the 
endplates of E16 γ/ε-fc embryos does not appear to be significantly different from that 
of their WT littermates. In the WT endplates, receptor density remains constant 
between E16 and E18, but a change can be detected in the γ/ε-fc endplates and 
possibly correlates in part with the increase in endplate size. In the endplates of E18 
embryos, a significant reduction of AChR density (about 40%) can be observed when 
compared to the endplates of E18 WT diaphragms. Furthermore, due to the presence 
of the GFP insertion in the γ/ε-fc subunit and the fluorescence increase due to FITC-
labeled α-bgtx, average density in the homozygous embryos might be overestimated, 
and the actual AChR density in γ/ε-fc embryos might be lower than the presented 
results. 
 
 
 
 
Fig. 11: Endplate Appearance and Receptor Density in E16 and E18 Embryos.  
(A) Comparison of endplates of WT and γ/ε-fc animals at embryonic days E16 and 
E18. While there are only minor morphological differences between E16 endplates, 
the E18 endplates of γ/ε-fc animals are larger and display a more speckled 
distribution of receptor clusters than in the WT littermates. Scale bar = 10 μm. (B) 
Receptor density measurements in E16 and E18 endplates, performed through 
fluorescence intensity analysis (n = 40, 3 embryos per point). Green: WT embryo; 
red: γ/ε-fc homozygous embryo. At embryonic day E16, no significant difference 
can be detected between AChR density in the γ/ε-fc as compared to their WT 
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littermates. At embryonic day E18, however, a significant (p = 0,0006) decrease in 
receptor density can be detected in the γ/ε-fc, in comparison to their WT littermates.  
 
Reduced AChR activity in the γ/ε-fc embryos caused not only a reduction in AChR 
density within the putative endplates, but also affected shape and size, as shown in 
Fig. 12 and 13. Fig. 12 shows average areas for endplates in E16 and E18 WT and γ/ε-
fc embryos. As shown in Fig. 12A, overall the average endplate area does not show 
any significant changes between WT and γ/ε-fc embryos at E16. Between E16 and 
E18, endplate areas in the WT embryos increases slightly, but γ/ε-fc endplates undergo 
a much more pronounced increase, and at E18, a significant difference emerges, with 
γ/ε-fc endplates being on average 20% larger than the endplates of WT littermates. 
However, the severity of these changes appears to vary in different regions of the 
diaphragm; Fig. 12B shows a comparison of the average endplate areas for WT and 
γ/ε-fc embryos in the lumbar or sternal region of the diaphragm, both at E16 and E18. 
At E16, there are no significant differences between endplate areas in either the 
lumbar or the sternal region of γ/ε-fc embryos in comparison to WT littermates. At 
E18, endplate area in the lumbar region of γ/ε-fc embryos does not differ significantly 
from WT littermates, but the average endplate area in the sternal region is instead 
significantly increased by about 25%. 
 
 
 
 
 
Fig. 12: Endplate Area in E16 and E18 Embryos.  
(A) Comparison of average endplate areas in E16 and E18 WT and γ/ε-fc 
homozygous embryos (n = 60 endplates among 3 embryos). Endplates appear to be 
significantly larger in E18 γ/ε-fc homozygous animals than in their WT littermates (p 
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= 0,0009). (B) Comparison of average endplate areas in the sternal and lumbar 
regions of the diaphragms of E16 and E18 embryos. Green: WT sternal region; red: 
γ/ε-fc sternal region; blue: WT lumbar region; orange: γ/ε-fc lumbar region. No 
significant differences can be detected in the areas of sternal endplates in E16 
embryos (p = 0,77) as well as in the areas lumbar endplates, both in E16 and E18 
embryos (p = 0,09 and 0,07, respectively). However, the average endplate area in the 
sternal region of E18 embryos is significantly increased in comparison to wild type 
(p = 0,007). 
 
Fig. 13 shows the average circularity of endplates in E16 and E18 WT and γ/ε-fc 
embryos as a quantitative measurement of their shape. Circularity is a measurement 
indicating regularity of object shapes. It is calculated according to the formula 
circularity = 4π (area / perimeter2). A value of 1,0 indicates a perfect circle, while a 
value of 0,0 indicates a completely irregular polygon. Fig. 13A compares the average 
circularities of endplates at ages E16 and E18; the data clearly indicate that the 
average endplate shape in γ/ε-fc animals is significantly more irregular than in WT 
littermates, both at E16 and E18.  
 
      
 
 
 
Fig. 13: Shape (Circularity) in E16 and E18 Embryos.  
(A) Comparison of average endplate circularities in E16 and E18 WT and γ/ε-fc 
homozygous embryos (n = 20, 3 embryos per point). In both cases, endplates are 
significantly more irregular in shape than the endplates of WT embryos (p < 0,0001 
both in E16 and E18 embryos). (B) Comparison of average endplate circularities in 
the sternal and lumbar regions of the diaphragms of E16 and E18 embryos. Green: 
    E16                                  E18  E16 
Sternal 
E16 
Lumbar 
E18 
Sternal 
E18 
Lumbar 
  A                                                B
42 
 
WT sternal region; red: γ/ε-fc sternal region; blue: WT lumbar region; orange: γ/ε-fc 
lumbar region. At both embryonic ages, endplate shape is significantly affected in all 
regions of the diaphragm, although the difference between WT and γ/ε-fc 
homozygous animals appears be reduced at E18 (p < 0,0001 for both sternal and 
lumbar regions at E16; p < 0,0001 for sternal region at E18, p = 0,0003 for lumbar 
region t E18). 
 
However, there appears to be a slight tendency towards a reduction in the difference 
between WT and γ/ε-fc embryos between E16 and E18. Fig. 13B compares average 
circularities in the lumbar and sternal regions of WT and γ/ε-fc embryos: significant 
differences in shape are apparent in both regions when comparing homozygous 
endplates with WT endplates. However, the tendency described above appears to be 
stronger in the E18 lumbar region than in the E18 sternal region, though no statistical 
significance can be ascribed to it.  
 
 
6.3.2     Distribution of Endplates 
 
AChE present in diaphragm endplates was stained using the Koelle method, and 
pictures were taken using conventional light microscopy (Fig. 14). 
The distribution of endplates in the diaphragms of E16 and E18 γ/ε-fc embryos is 
largely different from the normal distribution found in WT embryos. The central 
endplate band, clearly visible in WT diaphragms, is severely affected by reduced 
AChR activity and endplates are far more widely dispersed along the diaphragm width 
(Fig. 14A). This phenotype is especially noticeable in the lumbar region of the 
diaphragm, due to the larger average length of muscle fibers. 
The quantification of average endplate distribution width in the sternal (Fig. 14C) and 
lumbar (Fig. 14D) regions of WT and γ/ε-fc E16 and E18 diaphragms confirms that 
endplates in embryos with reduced AChR activity are distributed on a much broader 
area, at least twice as wide as the area covered by the endplate band of WT embryos. 
However, while the endplate band appears to be almost completely disrupted in the 
lumbar regions, it is clearly still present in the sternal regions, although greatly 
widened in comparison to the WT endplate band. This difference is statistically 
significant in both sternal and lumbar regions, both at E16 and E18. Fig. 14E 
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compares the total endplate distribution widths of embryos within the same group (WT 
or γ/ε-fc) between ages E16 and E18. Whereas in the WT diaphragm the width of the 
endplate band (expressed as percentage of total diaphragm width) is significantly 
reduced between E16 and E18 due to the growth pattern of myotubes, which grow by 
incorporating myoblasts at the distal ends, there is no significant difference between 
the width of the endplate band in γ/ε-fc embryos between E16 and E18, suggesting 
that muscle fiber growth is impaired, and/or that new endplates continue being formed 
at more distal regions of myotubes even at late pregnancy stages.  
 
 
 
Fig. 14: Endplate Distribution in WT and γ/ε-fc Embryos.  
(A, B) Composite pictures of E18 left hemidiaphragms from WT and γ/ε-fc 
homozygous embryos. In the WT diaphragm (A), the central endplate band is clearly 
recognizable and no endplates can be found in the inner or outer regions of the 
diaphragm. In the γ/ε-fc homozygous diaphragm (B), endplate distribution is much 
broader, and the central endplate band has almost completely disappeared in the 
lumbar regions; endplates are scattered on a much wider area. Endplate distribution 
width measurements were taken by selecting lines across diaphragm regions (in red) 
and measuring the total width of the diaphragm, and the distance between the first 
and last discernable endplate along the line. Scale bar = 1 mm. (C) Comparison of 
endplate distribution widths between WT (green) and γ/ε-fc (red) embryos in the 
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sternal region S2 at ages E16 and E18 (E16 p < 0,0001; E18 p = 0,008). Widths are 
expressed as percentages of total diaphragm width. (D) Comparison of endplate 
distribution widths between WT (green) and γ/ε-fc (red) embryos in the lumbar 
region S1 at ages E16 and E18 (E16 p = 0,0003; E18 p = 0,004). Widths are 
expressed as percentages of total diaphragm width. (E) Comparison of total endplate 
distribution widths between embryos with the same group (green: WT; red: γ/ε-fc) at 
ages E16 and E18 (WT p = 0,022; γ/ε-fc p = 0,6). Widths are expressed as 
percentages of total diaphragm width. n = 9, 2 embryos per point. 
 
 
6.3.3     General Innervation Pattern 
 
Motor axons were stained using anti-neurofilament primary antibodies and rhodamine-
labeled secondary antibodies. Pictures were taken using confocal microscopy. 
The analysis of diaphragms aged E16 and E18 reveals gross physiological aberrations 
in the innervation patterns of γ/ε-fc embryos (Fig. 15A-C). The growth of secondary 
neurites in WT diaphragms is restricted to the medial diaphragm where they innervate 
NMJs and does not extend any further, whereas neurites in the g/e-fc diaphragms 
continue growing, reaching the edge of the diaphragm and showing no detectable 
retraction even at E18. In WT embryos, neurites extend from the phrenic nerve in an 
orderly fashion, while γ/ε-fc neurites display a nearly complete loss of directionality, 
growing randomly and branching wildly. The total number of neurites in the 
diaphragm of γ/ε-fc embryos and their average length are also significantly increased 
when compared to WT littermates (Fig. 15D-G).  
In order to accurately quantify the average number of neurites and their average 
length, composite pictures of the left (S1-2) and right (S3-4) hemidiaphragms were 
analyzed separately. As shown in Fig. 15D, while there is no significant difference in 
the number of neurites between hemidiaphragms of the same embryos at embryonic 
day E16, the average number of neurites in either hemidiaphragm of γ/ε-fc embryos is 
significantly increased in comparison to the same hemidiaphragm in WT embryos (p = 
0,009 for S1-2 and p = 0,0008 for S3-4). The same analysis performed at age E18 (Fig. 
15E) shows that aberrant neurite growth is not inhibited in the γ/ε-fc embryos, and the 
average number of neurites in either hemidiaphragm appears to further increase.  
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Fig. 15: Differences in the Innervation Pattern of WT and γ/ε-fc Embryos.  
(A, B) Composite pictures of E18 diaphragms from WT and γ/ε-fc homozygous 
embryos. Neurites have been traced with the NeuronJ plug-in for ImageJ in order to 
follow their branching pattern. In the WT diaphragm (A), secondary neurites (green) 
branch from the phrenic nerve (red) and reach the central region of the diaphragm, 
where they innervate the NMJs of the central endplate band. In the γ/ε-fc 
homozygous diaphragm (B), neurite growth does not follow any discernible pattern, 
it is not restricted to the central endplate band, nerves reach the edge of the 
diaphragm without retracting, and directionality of growth is completely abolished. 
Branching is also highly increased. Scale bar = 1 mm. (C) Close-up pictures of the 
S1 region in WT and γ/ε-fc embryos aged E16 and E18. The increase in neurite 
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number and length is clearly visible. Scale bar = 100 μm. (D) Average number of 
neurites in the left (S1-2) and right (S3-4) hemidiaphragm of WT and γ/ε-fc embryos 
at E16. (E) Average number of neurites in the left (S1-2) and right (S3-4) 
hemidiaphragm of WT and γ/ε-fc embryos at E18.  
(F) Average length of neurites in the left (S1-2) and right (S3-4) hemidiaphragm of 
WT and γ/ε-fc embryos at E16. (G) Average length of neurites in the left (S1-2) and 
right (S3-4) hemidiaphragm of WT and γ/ε-fc embryos at E18. n = 3 embryos per 
point. 
 
The average length of neurites is also affected by reduced AChR activity (Fig. 15F and 
G). Fig. 15F represents the average length of neurites from the left and right 
hemidiaphragm of E16 WT and γ/ε-fc embryos. Minor differences between the left 
and right hemidiaphragms in the same embryos can be attributed to the asymmetry of 
the innervation pattern (as shown in Fig. 8). The average neurite length is significantly 
increased in both hemidiaphragms of the γ/ε-fc embryo in comparison to the WT 
littermate (p = 0,02 for S1-2 and p = 0,005 for S3-4); this difference loses its 
significance at E18 (Fig. 15G) due to the high variability of the average neurite length 
in different γ/ε-fc embryos (p = 0,07 for both left and right hemidiaphragms).  
The analysis of neurite individual length details finer differences between WT and γ/ε-
fc embryos at E16 and E18.  
Fig. 16A-D display the percentage of total neurites in the left (A, C) and right (B, D) 
hemidiaphragms of WT and γ/ε-fc animals aged E16, arranged by length (in μm). In 
the WT diaphragm, the largest percentage of neurites is between 40 and 160 μm long, 
while the γ/ε-fc diaphragm displays a more homogeneous distribution of neurites 
across the spectrum of lengths. Organizing these data as a cumulative probability 
distribution (Fig. 16E-F), the K-S test demonstrated that the shift in neurite 
distribution along length categories is statistically significant (p = 0,03 for S1-2, p = 
0,009 for S3-4).  
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Fig. 16: Percentages of Total Neurites by Length in Diaphragms of E16 Embryos.  
(A, C) S1-2 hemidiaphragms of WT and γ/ε-fc embryo, respectively; while most WT 
neurites are between 40 and 160 μm long, γ/ε-fc neurites are more homogeneously 
distributed along the spectrum of lengths. The same can be noticed comparing the 
S3-4 hemidiaphragms of WT and γ/ε-fc embryos (B, D). (E, F) Comparison of 
cumulative probability distributions of neurite lengths in S1-2 hemidiaphragms (E) 
and S3-4 hemidiaphragms (F) of WT (blue) and γ/ε-fc (red) embryos. In both cases, 
γ/ε-fc neurites are distributed along a wider spectrum of lengths, as described above. 
n = 3 embryos per point. 
 
The same analysis was also performed on E18 embryos (Fig. 17A-D), showing no 
change in the situation in comparison to E16, with γ/ε-fc neurites remaining 
distributed along a significantly wider spectrum of lengths than neurites in the WT 
littermate (Fig. 17E-F; p = 0,002 for S1-2, p < 0,0001 for S3-4). 
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Fig. 17: Percentages of Total Neurites by Length in Diaphragms of E18 Embryos.  
(A, C) S1-2 hemidiaphragms of WT and γ/ε-fc embryo, respectively; as already 
demonstrated in E16 embryos, most neurites in the WT diaphragm are between 40 
and 160 μm long, while the γ/ε-fc diaphragm shows a much wider distribution. The 
same can be noticed comparing the S3-4 hemidiaphragms of WT and γ/ε-fc embryos 
(B, D). (E, F) Comparison of cumulative probability distributions of neurite lengths 
in S1-2 hemidiaphragms (E) and S3-4 hemidiaphragms (F) of WT (blue) and γ/ε-fc 
(red) embryos. The data suggest that no improvement occurs in the length 
distribution of γ/ε-fc embryos at late pregnancy stages. n = 3 embryos per point. 
 
 
6.3.4     Endplate Innervation 
 
Nerve terminals in E18 diaphragms were stained with rabbit anti-synaptophysin 
primary antibodies and rhodamine-labeled anti-rabbit secondary antibodies, in order to 
study the presence of innervation in individual endplates.  
Due to the disorganization of the innervation pattern and the lack of endplate pre-
patterning along the central region of the muscle fibers in the diaphragm (Fig. 18A-B), 
stained nerve terminals in the γ/ε-fc homozygous embryo are not restricted to the 
WT 
γ/ε-fc 
A                                        B 
 
 
 
 
 
C                                        D 
 
 
 
 
 
E                                        F 
 
 
 
    S1-2                                                                             S3-4 
%                                                                 % 
%                                                                 % 
%                                                                 % 
49 
 
central endplate band, but are spread over the whole diaphragm; all visible endplates 
in the γ/ε-fc homozygous mouse are innervated (Fig. 18C-D).  
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Fig. 18: Innervation of Individual Endplates.  
(A, B) Overviews and close-ups of E16 (A) and E18 (B) diaphragms, stained with 
anti-neurofilament antibody (red) and FITC-labeled a-bgtx (green). The chaotic 
meshwork of neurites in the γ/ε-fc embryos appears to reach most endplates. Scale 
bars = 50 μm. (C) Close-up of E18 WT and γ/ε-fc homozygous diaphragms. Green: 
α-Bgtx-labeled endplates; red: anti-synaptophysin antibody. Although nerve 
terminals in the γ/ε-fc homozygous embryo are entirely disorganized, all visible 
endplates are innervated. Scale bar: 10 μm. (D) zoomed-in view of a γ/ε-fc endplate, 
showing the nerve terminal (red) which colocalizes with the green fluorescence of 
the AChRs. Scale bar: 10 μm. (E) Percentage of innervated endplates in WT and γ/ε-
fc embryos. No significant difference can be detected (p > 0,05, n= 2). 
 
Unlike nerve terminals in WT embryos, neurites in γ/ε-fc  homozygous embryos do 
not stop their growth upon innervating an endplate, but continue growing and 
branching past the innervation point (Fig. 18D). As shown in Fig. 18E, almost all 
detectable endplates are innervated, both in WT and γ/ε-fc embryos.  
 
 
6.3.5     Presence of Multiple Synapses 
 
In order to study the possible presence of multiple synapses on muscle fibers, slow 
muscle fibers were stained with anti-slow skeletal myosin antibody; endplates were 
stained with FITC-labeled α-bungarotoxin; and neurofilaments were stained with α-
neurofilament antibody. Pictures were taken through confocal microscopy, and 
analyzed by optically following several muscle fibers across the diaphragm in order to 
pinpoint the location of their endplates.  
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Fig. 19A shows close-up pictures of E16 diaphragm muscle fibers, while Fig. 19B and 
C show the results of the analysis. On average, there is a significant presence of 
multiple endplates on the same muscle fiber in γ/ε-fc embryos, with an average of 1,8 
endplates per muscle fiber (Fig. 19B). The analysis of the percentage of muscle fibers 
displaying multiple endplates (Fig. 19C) reveals that roughly one-third of all muscle 
fibers in the E16  γ/ε-fc embryo contain one endplate, while the remaining muscle 
fibers present multiple synapses in a variable number, usually between two and three, 
with a very small number of fibers displaying up to five different endplates.  
 
 
 
 
 
 
 
Fig. 19: Presence of Multiple Endplates in E16 Embryos.  
n = 50 muscle fibers. (A) Close-ups of diaphragm muscle fibers in WT and γ/ε-fc 
E16 embryos. The asterisks mark the location of endplates on individual muscle 
fibers. While muscle fibers in the WT embryo display only one endplate each, 
muscle fibers in the g/e-fc embryo often display multiple endplates. (B) Average 
number of endplates on the muscle fibers of WT (green) and γ/ε-fc (red) E16 
embryos. The number is significantly increased in the γ/ε-fc embryos (p < 0,0001). 
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(C) γ/ε-fc muscle fiber percentages grouped by number of endplates on the 
individual fiber. About one-third of all slow muscle fibers present one endplate, 
whereas most slow muscle fibers present multiple endplates. Values are 
underestimated due to the difficulty of analysis in the γ/ε-fc embryo.  
 
 
6.3.6     Motoneuron Survival 
 
 
Motoneurons in the brachial lateral motor column (LMC) of the spinal cord were 
immunostained with goat anti-ChAT primary antibodies coupled with biotinylated 
anti-goat secondary antibodies. Pictures were taken using a light microscope, and 
analyzed through ImageJ (Fig. 20A), in order to analyze the retraction of excess 
motoneuron projections from the diaphragm in late embryonic stages.  
 
 
 
Fig. 20: ChAT Staining of Motoneurons in the LMC.  
(A) Close-up of ChAT staining in whole-mount paraffin section in the cervical 
region of a wild-type E18 animal. Motoneurons are marked by dark staining in the 
lateral motor column. Scale bar = 200 μm. (B) Comparison of motoneuron numbers 
in WT (green) and γ/ε-fc (red) embryos at age E16 and E18. Values were collected 
from single animals, and mean total motoneuron numbers are shown.  
 
Based on the comparison of total motoneuron numbers (Fig. 20B), there is little or no 
difference in the average number of total motoneurons in the LMCs of γ/ε-fc embryos 
when compared to WT littermates (p = 0,6), whereas there is a significant difference at 
late embryonic stages (p = 0,03). The number of motoneurons in WT embryos 
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decreases dramatically as a consequence of motoneuron death, whereas the number of 
motoneurons in the γ/ε-fc embryos remains stable. 
 
 
6.3.7     Muscle Fiber Growth 
 
Muscle fibers were stained with mouse anti-slow skeletal myosin primary antibodies 
coupled with AMCA-labeled anti-mouse secondary antibodies, and analyzed through 
confocal microscopy (Fig. 21A, B). 
The organization of slow muscle fibers is partially disrupted by reduced activity of the 
AChRs; this disruption appears to be localized in the lumbar regions of the γ/ε-fc 
homozygous diaphragm, as well as the central boundary between sternal and lumbar 
regions, whereas the slow muscle fibers in the sternal regions remain relatively 
unaffected by the γ/ε-fc mutation. In the affected regions, slow muscle fibers partially 
lose their directionality, and form a loose meshwork of fibers woven through the 
unaffected muscle fibers. 
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Fig. 21: Slow Muscle Fiber Organization.  
 (A) Comparison between the slow muscle fiber organization in a γ/ε-fc homozygous 
embryo aged E16 and in a WT littermate. The organization of slow muscle fibers is 
partially disrupted by lack of activity on the part of the AChRs; this disorganization 
is more evident in the lumbar regions (S1 and S4) of the diaphragm, whereas it is 
much less noticeable in the sternal regions  (S2 and S3). (B) Close-up of region S1-
S2 of the WT and γ/ε-fc diaphragm; the paths of several muscle fibers are traced in 
order to highlight the aberrant muscle fiber organization in the γ/ε-fc embryo, 
including the abnormal length, directionalitry and crisscrossing of muscle fibers. 
Scale bar = 100 μm. (C) Comparison between the average diaphragm thickness in a 
γ/ε-fc homozygous embryo aged E16 and in a WT littermate. The ~15% decrease in 
thickness appears to be significant (p < 0,05). 
 
Diaphragm thickness in E16 γ/ε-fc embryos appears to be significantly reduced by 
~15% in comparison to their WT littermates (Fig. 21C). 
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6.3.8     Muscle Fiber Diameter 
 
Stained slow muscle fibers were analyzed through confocal microscopy, and data were 
collected through ImageJ and Leica LAS AF software (Fig. 22A, B). 
Fig. 22B shows that the diameter of γ/ε-fc slow muscle fibers is not significantly 
different from the diameter of WT slow muscle fibers, suggesting that lack of AChR-
mediated activity has little or no effect on the development and differentiation of 
individual muscle fibers, despite its effects on the overall diaphragm architecture.  
 
 
 
 
Fig. 22: Slow Muscle Fiber Diameter.  
 (A) Close-up of slow muscle fibers in the S1-S2 region of WT and γ/ε-fc 
homozygous E16 embryos. Although fiber organization in the homozygous embryos 
is partially disrupted in comparison to WT embryos, no appreciable difference can 
be noticed between the sizes of the individual muscle fibers. Scale bar = 25 μm. (B) 
Comparison of muscle fiber diameters between WT and γ/ε-fc homozygous E16 
embryos. No significant difference can be detected (p = 0,05, n = 12 muscle fibers in 
each animal, one animal per experimental point).  
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6.4     Gene Profiling 
 
6.4.1     mRNA Gene Profiling 
 
Leg muscles from WT and γ/ε-fc homozygous embryos aged E16 and E18 were used 
to extract mRNA. The samples were converted to cDNA and the mRNA expression 
levels of different proteins were calculated through Real-Time PCR both for E16 
embryos (Fig. 23A, C) and E18 embryos (Fig. 23B, D). 
Data from γ/ε-fc heterozygous and homozygous embryos were quantified either 
relative to the mRNA expression levels in WT embryos (Fig. 23A, B) or to the mRNA 
expression levels of the housekeeping protein glyceraldehyde-3-phosphate 
dehydrogenase, GAPDH (Fig. 23C, D). 
Two different probes were used to analyze the total expression levels of the WT γ 
subunit and the transgenic γ/ε-fc subunit. The first probe recognized a region coded by 
exons 2 and 3 of the γ subunit cDNA sequence, and would recognize both WT γ and 
transgenic γ/e-fc. The data obtained from this probe represented the total expression 
levels of the γ plus γ/ε-fc subunits. In homozygous γ/ε-fc embryos, the data obtained 
from this probe represented the total expression level of the γ/ε-fc subunit alone.  
A second probe recognized a region coded by exons 6 and 7 of the γ subunit cDNA 
sequence, and would recognize the WT γ subunit but not the γ/e-fc subunit; this probe 
was used to determine the reduction of the expression levels of WT γ subunit in 
heterozygous embryos, or its absence in homozygous embryos. 
Further probes were used to analyze the expression levels of various mRNAs 
codifying for the α and ε subunits, as well as MuSK. 
Fig. 23A and B show results relatively to the WT expression levels. No significant 
change in the levels of the α or ε subunits can be detected, and the expression of 
MuSK is not significantly affected either, although at E16 there appears to be a 
tendency for MuSK expression levels to increase in the heterozygous and homozygous 
embryos, and for the ε subunit to increase in the E16 homozygous embryo. The total 
expression levels of the γ and γ/ε-fc subunits decreases slightly in the heterozygous 
embryo, as expected; since in the homozygous embryo, this data actually describes the 
total mRNAs of the two γ/ε-fc alleles, it implies that each γ/ε-fc allele maintains an 
expression level equal to roughly 40% that of the γ subunit allele in the WT embryo. 
57 
 
The data also confirm that expression of γ subunit mRNA is completely abolished in 
the γ/ε-fc homozygous embryos. 
 
 
 
Fig. 23: Gene Profiling in E16 and E18 Embryos.  
Yellow: α subunit; green: exons 2-3 of γ subunit (total expression levels of γ plus 
γ/ε-fc subunits); red: exons 6-7 of γ subunit (expression levels of WT γ subunit); 
blue: ε subunit; purple: MuSK.  n = 3 embryos per point. (A) Quantification of 
expression levels in E16 embryos, relative to WT. (B) Quantification of expression 
levels in E18 embryos, relative to WT. (C) Quantification of expression levels in 
E16 embryos, relative to dehydrogenase GAPDH. (D) Quantification of expression 
levels in E18 embryos, relative to dehydrogenase GAPDH.  
 
Fig. 23C and D present the same data relatively to the expression levels of the 
housekeeping dehydrogenase GAPDH, which is used as a standard in order to more 
directly compare WT expression levels with those of the heterozygous and 
homozygous γ/ε-fc embryos. The data confirm the relatively high expression levels of 
the γ/ε-fc alleles, which are similar to WT in the heterozygous animals, and ~50% of 
WT in γ/ε-fc homozygous embryos. The slight differences in MuSK, α subunit and ε 
subunit expression levels between WT, heterozygous and γ/ε-fc homozygous embryos, 
A                                                    B 
 
 
 
 
 
 
 
C                                                    D 
 
het                              hom                                              het                              hom 
WT                   het                  hom                                 WT                   het                  hom 
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on the other hand, appear not to be statistically significant. The results further clarify 
that the replacement of the functional γ subunit with the reduced-affinity γ/ε-fc subunit 
does not lead to overexpression of other AChR subunits in an attempt to rescue 
functionality, nor does it significantly affect the regulation of upstream members of 
the agrin signal cascade such as MuSK. 
 
 
6.5     Phenotype Rescue 
 
Attempts to rescue the phenotype of the γ/ε-fc mouse line are based upon the 
assumption that, because AChRs containing the γ/ε-fc subunit have reduced affinity 
for ACh, transiently increasing the quantity of released ACh in the embryonic and 
early postnatal NMJs may activate the AChRs and allow the pups to survive after 
birth. Because the γ/ε subunit switch occurs shortly afterwards, the γ/ε-fc subunit 
would be gradually replaced by the ε subunit, and subsequently reducing the quantity 
of released ACh to physiological levels should not lead to death.  
 
 
6.5.1     3,4-Diaminopyridine  
 
3,4-diaminopyridine (3,4-DAP, Fig. 24A) is an organic compound with the formula 
C5H3N(NH2)2 , which is derived from pyridine through substitution of the 3 and 4 
positions with an amino group. It facilitates synaptic transmission by prolonging the 
open time of voltage-gated K+ channels, greatly increasing the release of ACh quanta 
in the NMJ (Katz and Miledi, 1979). It is mostly used as an experimental drug for the 
treatment of Lambert-Eaton CMS, a presynaptic FCCMS displaying impaired ACh 
release (Sanders, 1998), where it is moderately to largely effective in the majority of 
patients, with very little side effects. The beneficial effects of one dose last for 3 to 8 
hours after administration and it is lost after 24 hours if the drug is withdrawn. In 
humans very little is known about possible side effects of 3,4-DAP during pregnancy, 
though one study suggests they are negligible (Pelufo-Pellicer et al., 2006). In mice, 
the LD50 of 3,4-DAP is 13 mg/Kg after intravenous injection and 35 mg/kg after 
subcutaneous administration; death in mice is due to uncontrolled convulsions.  
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6.5.2     Rescue Strategy 
 
Because of several factors, such as the short effectiveness of 3,4-DAP, the need for 
constant administration for about two weeks starting from E12, the poor absorption 
rate of orally administered 3,4-DAP and the unfeasibility of administration through 
multiple daily intravenous injections or catheter implantation in mice, the current 
rescue strategy focuses on the subcutaneous implantation of osmotic pumps capable of 
constantly delivering a known amount of drug for the whole duration of treatment.  
 
The results of preliminary tests performed on WT animals about the feasibility of this 
approach, in regard to the amount of 3,4-DAP crossing the placenta and entering the 
embryo’s bloodstream, as well as the amount of drug absorbed by pups through the 
mother’s milk during postnatal life are shown in Fig. 24B.  
 
 
Fig. 24: Preliminary Results of Pharmacological Rescue.  
(A) Structure of 3,4-DAP. (B) Preliminary results of implantation of osmotic pumps 
in WT pregnant females: levels of 3,4-DAP detected in the blood of mothers (red) 
and embryos or pups (orange) through HPLC at different time points (1 week after 
implantation, P0 and 2 weeks after implantation) after subcutaneous implantation of 
osmotic pumps filled with saturated 3,4-DAP solution. 
 
These preliminary results suggest that 3,4-DAP crosses the placenta with difficulty, 
reaching steady concentrations reduced by about 80% in comparison to the drug 
concentration detected in the mother’s bloodstream; however, newborn pups appear to 
assume 3,4-DAP through their mother’s milk, and the drug’s concentration in the 
bloodstream of newborn pups appears to be much higher than the levels detected in the 
A                                   B 
           1 week                   P0                    2 weeks          
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mother’s bloodstream, suggesting that pups might be unable to dispose of the drug, 
perhaps due to the immaturity of their systems.  
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7. DISCUSSION 
 
 
It is currently known that proper development of the NMJ occurs through the 
coordinated action of the muscle fiber membrane, the nerve terminal, the Schwann 
cell and the nearby glial cells. Based on the current state of knowledge, putative 
pathways have been proposed to describe the events leading to the establishment and 
maturation of a proper NMJ, but despite its status as the best studied synapse, many 
of the biochemical processes leading to its development are still largely unknown.  
However, the NMJ’s relative simplicity and the comparatively small number of 
molecules involved in these processes offer a great advantage in comparison to the 
study of other synapses. Using the NMJ as a model system, then, the elucidation of 
the molecular mechanisms leading to its development and maturation may offer us 
greater insight into the general development process of other synapses, such as brain 
synapses, as well.  
The current paradigm of NMJ development and of the contribution on the part of 
individual molecules to the overall differentiation of the synapse (4.3.5) is based on 
insights gained from the many transgenic mouse lines created in the last decade. It is 
now apparent that neither nerve nor muscle are exclusively responsible for the 
development of the NMJ, but it is rather the interaction between nerve- and muscle-
derived factors that leads to the formation of a proper synapse.  
For instance, studies on mice with genetically aneural muscles revealed that the 
clustering and pre-patterning of AChRs along the central endplate band occurs even 
in the absence of innervation (Lin et al., 2001; Yang et al., 2000; Pun et al., 2002), 
suggesting that these events are not initiated by nerve-derived factors, although the 
maintenance of these clusters requires innervations. Additional studies in zebrafish 
also showed that aneural clusters could be incorporated into synapses through contact 
with the nerve terminal, and that this contact could in turn influence presynaptic 
development (Flanagan-Steet et al., 2005).  
The analysis of animals in which neurotransmission in the NMJ was abolished by 
knocking out ChAT, which is the only enzyme synthetizing ACh, showed defects in 
postsynaptic differentiation and in presynaptic nerve growth, including abnormal 
nerve branching, presence of multiple endplates on the same muscle fiber, and a 
widened endplate band (Misgeld et al., 2002; Brandon et al., 2003). These studies 
also showed additional defects at late embryonic stages, such as larger endplate sizes 
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and irregular shapes, which suggested a modulatory role for synaptic activity in 
regard to postsynaptic differentiation.  
Agrin knock-out mice displayed aberrations in postsynaptic differentiation (Gautam 
et al., 1996), but AChR cluster formation was not abolished, although AChR clusters 
dispersed more quickly in agrin mutant mice than in aneural muscles, suggesting that 
agrin might play a role in maintaining the synapse by counteracting the effect of a 
nerve-derived dispersal factor, later discovered to be ACh (Misgeld et al., 2005; Lin 
et al., 2005) through studies in agrin-ChAT knock-out animals in which it was 
discovered that synapse inactivity rescued the agrin phenotype. 
AChR, then, plays a central role in the establishment, maintenance and maturation of 
the NMJ. Its presence attracts the presynaptic nerve terminal, contributes to the 
stabilization of nerve-muscle contacts, and its activity is important during later 
embryonic stages, ensuring the proper development of pre- and postsynaptic 
structures. Further proof of the importance of its role in the development of the NMJ 
is given by the observation that mutations in AChR subunits lead to defects in 
neuromuscular transmission which are manifested as CMSs (Müller et al., 2007; 
Engel et al., 2003a).  
The effect of AChR activity on the maturation of the NMJ without disrupting 
molecular pathways can be studied in several ways. One approach would be to study 
the development of the NMJ during embryonic and early postnatal life in a transgenic 
mouse line in which receptor density is dramatically decreased; one mouse line 
generated in our lab, the AChRγ-GFP line, displays this feature due to highly reduced 
expression of the γ-GFP transgenic subunit (Yampolsky et al., 2008). 
Another possibility would be to use a transgenic mouse line in which fetal-type 
AChR displays reduced affinity for ACh, leading to the near-absence of synaptic 
activity in the NMJ during embryonic development. The goal of this thesis was to 
characterize such a knock-in mouse line, generated in our lab and expressing 
structurally intact but functionally silent AChRs. 
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7.1     The γ/ε-fc Mouse Line 
 
The γ/ε-fc mouse line enables the study of the effects of synaptic activity on the 
development of the NMJ without disrupting other molecular pathways depending on 
the presence of the AChR. In this line, the fetal-type γ subunit of the AChR is 
replaced by the transgenic γ/ε-fc subunit, which permits the assembly of structurally 
intact AChRs with lower conductivity.  
The γ/ε-fc subunit is based on a point mutation first discovered in CMS patients 
(Ohno et al., 1986), in which the replacement of a single amino acid in the ε subunit 
(proline 121 into leucine, P121L) reduces overall channel open time.   
 
 
7.1.1     Generation of the γ/ε-fc Knock-In Mouse Line 
 
The amino acid sequence of AChR subunits is highly conserved, both among 
different subunits in a single species, and between the sequences for the same subunit 
in different species; proline 121 is conserved in all of them (Peter C., dissertation 
2003). The P121L mutation is located on the extracellular domain of the ε subunit, 
near the binding site for ACh (Miyazawa et al., 2003) and it was shown through cell 
culture studies to affect channel opening rate, as well as affinity for ACh in the open 
channel state (Ohno et al., 1996). Xenopus oocytes studies in which the P121L 
mutation was introduced into the cDNA codifying for different subunits by changing 
one base (C441T), and the resulting AChRs were analyzed for their 
electrophysiological properties revealed that the mutation had maximum effect when 
localized in the ε subunit, without significantly affecting AChR expression and 
translocation to the membrane (Peter et al., 2005). This observation was the basis for 
the generation of a transgenic construct composed of a hybrid γ/ε subunit, offered by 
Dr. Michael Koenen and mutated with P121L, which was successfully used to 
generate the γ/ε-fc mouse line (Peter C., dissertation 2003).  
Because of the strongly reduced activity of the AChR at physiological concentrations 
of ACh during embryonic life, the γ/ε-fc knock-in mouse line offers new insights in 
the study of NMJ development and the role played in it by AChR-mediated synaptic 
activity. Its advantages lie in the presence of structurally intact AChRs on the 
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postsynaptic membrane, which ensures that observable phenotypes are caused only 
by reduced activity as opposed to complete absence of the AChR and disruption of 
related molecular pathways, and in the possibility to study embryonic development of 
the NMJ lacking synaptic activity without need for toxin administration, thereby 
eliminating the risk of undesirable toxin-related side effects.  
 
 
7.1.2     General Phenotype and Perinatal Death 
 
Whereas heterozygous animals show no phenotypical differences in comparison to 
WT, homozygous γ/ε-fc animals die at birth. Presumably, strongly reduced synaptic 
activity inhibits diaphragm contraction, preventing the animals from breathing and 
leading to death by asphyxiation. Perinatal death was observed in transgenic mouse 
lines lacking ChAT (Brandon et al., 2003; Misgeld et al., 2002), where synthesis of 
ACh was prevented, thus abolishing synaptic transmission in the NMJ. Interestingly, 
mice in which the γ subunit has been deleted do not necessarily die at birth, but 
survive for two days before dying, presumably due to impaired milk intake 
(Takahashi et al., 2002). Taken together, these results might suggest that in the 
absence of γ subunit, AChRε partially compensates for the lack of AChRγ. This 
mechanism, however, might not work if the γ subunit is present and functionally 
impaired.  It is worth noting that, in a complementary observation, transgenic mice in 
which the ε subunit is deleted display a continued presence of AChRγs in adult 
muscle, although this mechanism is not enough to ensure their survival for more than 
three months (Witzemann et al., 1996).  
Macroscopical differences could be noticed in homozygous γ/ε-fc animals when 
compared to WT littermates; some, such as hunched posture and lack of muscle 
tension, are characteristics of flaccid paralysis which are shared with homozygous 
animals from ChAT knock-out lines, and as such probably result from neuromuscular 
defects. Like ChAT-/- embryos, γ/ε-fc embryos were never seen to move and did not 
respond to stimulation even at late embryonic stages. In contrast to this, animals with 
highly reduced expression of the γ subunit, from the γ-GFP line, survived though 
expression levels of γ-GFP subunit mRNA in homozygous embryos were reduced to 
10% of WT levels (Yampolsky et al., 2008). This difference demonstrates that any 
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residual activity in the γ/ε-fc embryos has a negligible effect on NMJ maturation and 
embryo survival.  
 
 
7.1.3     Differences in Endplate Anatomy 
 
Although the early steps of neuromuscular synaptogenesis are independent from 
postsynaptic activity, later stages of NMJ stabilization and maturation are thought to 
be activity-dependent (Sanes and Lichtman, 1999).  
The γ/ε-fc embryos display noticeable differences in endplate anatomy in comparison 
to the WT littermates. These differences are minor at earlier embryonic stages, but 
become more significant and noticeable towards later embryonic stages, presumably 
reflecting the increased importance of the role played by postsynaptic activity in the 
maturation of the NMJ. Receptor density and endplate area in the γ/ε-fc embryos are 
similar to those of WT littermates around E16, but are changed significantly by E18. 
However, correlating the observed increase in endplate area (about 20% in E18 
embryos) with the 35-40% decrease in AChR density at the same embryonic age, the 
data suggest that lack of postsynaptic activity has no major effect on the overall 
number of receptors, which can be estimated to be reduced by less than 20%. In 
ChAT-/- animals of the same embryonic ages, on the other hand, the small changes in 
overall receptor density (<20%), if correlated with the large increase in endplate area 
(68-89%) suggest that overall receptor number is highly increased (Misgeld et al., 
2002). The increase in endplate area in γ/ε-fc embryos is also consistent with the 
paradigm that ACh might act as dispersal factor through AChR-mediated 
postsynaptic activity, and that strongly reducing or completely blocking postsynaptic 
activity abolishes the dispersal and removal effect of ACh (Misgeld et al., 2005; Lin 
et al., 2005), leading to increased clustering of AChRs at the endplate.  
Of particular interest is the possibility that endplate areas significantly differ from 
WT in the sternal regions of the E18 diaphragm, but not in the lumbar region, 
suggesting the possibility that different muscle fiber type composition or origin may 
have an impact on NMJ maturation and remodeling (Prakash et al., 1999; Prakash et 
al., 1995). Interestingly, the increase in endplate area in ChAT-/- animals (Misgeld et 
al., 2002) is about four times higher than the increase observed in γ/ε-fc animals; this 
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discrepancy may be explained by the fact that ChAT-/- embryos completely lack ACh 
signaling, possibly disrupting additional signaling pathways.  
The effect of lack of activity on endplate shape may be partly attributable to the 
increase in clustering of AChRs, leading to a more irregular shape in comparison to 
the smooth, ovoid shape of WT endplates. However, it has been suggested (Misgeld 
et al., 2002) that lack of postsynaptic activity may not only affect cluster growth, but 
accelerate endplate maturation as well. In light of this observation, it is possible to 
speculate that the more irregular shape of γ/ε-fc endplates might be at least in part due 
to muscle-autonomous differentiation. 
 
 
7.1.4     Aberrant Endplate Distribution 
 
The distribution of endplates along the muscle fibers is significantly affected by lack 
of postsynaptic activity. Endplates in the diaphragms of WT embryos are arranged 
along the so-called central endplate band, which corresponds to the innervation area 
of the phrenic nerve branches (Ackerman and Greer, 2007). This ordered distribution 
is severely disrupted in γ/ε-fc animals, where endplates are scattered along a much 
broader endplate band covering up to 35% of diaphragm width. Because the lumbar 
regions of the diaphragm are wider than the sternal regions, this increase in endplate 
band width appears as an almost-complete disruption of the endplate band 
organization. This aberrant distribution of endplates across the diaphragm due to lack 
of activity is already well-established at E16, and does not significantly change at late 
pregnancy stages, suggesting that this phenotype might either be independent from 
further maturation of the NMJ, or that a certain threshold of activity is needed before 
the phenotype can be rescued. 
Although AChRs cluster in a central endplate band even in the absence of motor 
innervation  (Yang et al., 2001), suggesting that the pre-patterning of the endplate 
band may be nerve-independent, an increase in its width in comparison to WT 
littermates seems to be a common phenotype in muscles where postsynaptic activity 
is absent (Lømo et al., 2003; Misgeld et al., 2002). This may partially depend on the 
presence of multiple endplates along individual muscle fibers, since activity is known 
to play a role in synapse establishment and in preventing the formation of additional 
extra-synaptic AChRs clusters on the same muscle fiber (Sanes and Lichtman, 2001). 
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In fact, a large percentage of muscle fibers in the γ/ε-fc embryo indeed displays the 
presence of multiple endplates, most or all of which appear to be contacted by 
neurites and display similar appearances. Individual muscle fibers have been detected 
in which up to five endplates could be distinguished, further supporting the 
implication that lack of activity might promote multiple endplate survival. In WT 
animals, in vivo studies suggest that synaptic activity leads to postsynaptic changes 
such as increases in transcription levels of AChR subunits in subsynaptic nuclei, 
downregulation of AChR subunit transcription in non-synaptic nuclei, and synaptic 
AChR metabolic stability; lack of activity at the NMJs of a single muscle fiber would 
therefore prevent these activity-dependent processes, allowing the formation of 
additional extrasynaptic AChR clusters. 
 
 
7.1.5     Changes in the Innervation Pattern 
 
In the diaphragms of WT embryos, the phrenic nerve enters the left hemidiaphragm, 
and splits into two main branches which then continue the innervation of the 
diaphragm in a highly ordered fashion, along the central endplate band (Ackelman 
and Greer, 2007; Greer et al., 1999). Neurites branch from the main phrenic nerve and 
contact nearby endplates, halting their progress and developing presynaptic 
specializations. This innervation pattern, however, is completely disrupted in γ/ε-fc 
animals. In the diaphragms of both E16 and E18 γ/ε-fc embryos, nerve branching is 
vastly increased, with γ/ε-fc diaphragms showing more than twice as many neurite 
branches in comparison to WT littermates, and no discernible organization or 
directionality can be noted. Branching appears to further increase between E16 and 
E18, while the average neurite length does not significantly change. In fact, an 
analysis of the percentage of total neurites in relation to their length shows that 
neurites are distributed much more evenly along the spectrum of measured lengths, 
and that no appreciable change occurs between E16 and E18, suggesting that no 
rescue occurs at late embryonic stages. Furthermore, our synaptophysin studies have 
shown that despite this highly aberrant pattern, individual neurites do innervate single 
NMJs, but rather than stopping at the innervation site, they extend further processes 
past the presynaptic specialization.  
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It has already been proposed that impaired activity at the level of the NMJ leads to 
increased motoneuron survival (Oppenheim et al., 2000; Oppenheim, 1991; Banks et 
al, 2001; Terrado et al, 2001), and in vivo studies on transgenic lines with reduced 
receptor density (Yampolsky et al., 2008) or lack of activity (Misgeld et al., 2002) 
have further confirmed this effect to varying degrees. The same appears to be true in 
the case of the γ/ε-fc animals, where motoneuron death seems to be completely 
abolished and the number of motoneurons remains stable during late embryogenesis, 
whereas it decreases dramatically in WT littermates. Furthermore, neurites in WT 
embryos grow past the central endplate band but, at late embryonic stages, they 
retract until no innervation occurs outside the central region of the diaphragm. In 
contrast to this, in the γ/ε-fc embryos, lack of AChR activity at the NMJ significantly 
affects not only neurite length, but also neurite branching. Neurites innervating NMJs 
and extending processes leading to further growth suggest that postsynaptic activity is 
not needed in order to recognize a cluster of AChRs and to stabilize it into a NMJ. 
However, an activity-dependent muscle-derived stop signal seems to be needed for 
the neurite to halt its growth. Lacking postsynaptic activity, neurites innervate the 
endplate properly, but extend further processes past the contact site. Interestingly, 
activity seems to also be needed to ensure the directionality of neurite growth, as the 
neurites in γ/ε-fc embryos grow randomly across the diaphragm, forming a complex 
and disorganized meshwork, in comparison to WT neurites which tend to grow 
parallel to muscle fibers.  
 
 
7.1.6     Defects in Muscle Fiber Organization 
 
The overall organization of individual muscle fibers in the diaphragms of γ/ε-fc 
embryos is largely abnormal in comparison to WT littermates. Many fibers, 
especially in the lumbar region of the diaphragm, appear to lose their directionality 
and cross over other fibers, or follow the inner surface of the ribcage, rather than 
growing perpendicularly to the central endplate band. Interestingly, however, this 
phenotype is restricted to a subset of the analyzed slow muscle fibers, whereas many 
other slow muscle fibers retain a normal phenotype and display no growth 
aberrations. Fast muscle fibers were not stained, and it is not possible at the moment 
to specify whether the phenotype is specific for slow muscle fibers, or if it affects all 
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muscle fibers to some extent. A similar phenotype has not been reported in 
denervated animals or ChAT-/- mice in which ACh signaling was completely 
abolished, but it might well correlate with what is known about myogenesis in 
vertebrates.  
Muscle formation in vertebrates occurs in two waves of myogenesis. Primary 
myogenesis occurs prior to the establishment of an innervation pattern in the muscle, 
and therefore it is not affected by synaptic activity; additionally, primary myotubes 
develop into both slow and fast muscle fibers (Zhang and McLennan, 1998). 
However, from about embryonic day E14 in the mouse, quiescent myoblasts begin 
proliferating and fusing into a wave of secondary myogenesis which correlates with 
the onset of innervation (Buckingham, 2001) and which leads to the formation of 
additional slow muscle fibers. Furthermore, zebrafish studies have demonstrated that 
while the inhibition of nerve activity during embryo development does not affect slow 
muscle fiber number or migration, it has a profound effect on myofiber organization, 
abolishing their directional growth and increasing their length (Brennan et al., 2005).  
Taken together with our results, this suggests the possibility that the organization of 
secondary, slow muscle fibers in the mouse diaphragm might be affected by an 
activity-dependent mechanism. Disruption of AChR-mediated activity would produce 
aberrations in the organization of secondary muscle fibers, but no changes in the 
organization of primary muscle fibers due to their activity-independent development. 
Interestingly, the diameter of the E16 slow muscle fibers in γ/ε-fc homozygous 
embryos was not significantly affected by lack of AChR-mediated activity in 
comparison to WT embryos, suggesting that minimal or no myofiber atrophy occurs 
despite lack of activity. Diaphragm thickness was somewhat reduced, presumably due 
either to atrophy, or to a slight decrease in overall number of muscle fibers. These 
data seemingly contradict the data reported for the ChAT-/- mice, which displayed 
high levels of myofiber atrophy, as well as extensive myofiber necrosis and a 
dramatic decrease in diaphragm thickness (Misgeld et al., 2002), already as early as 
E14. It was already suggested by in vitro studies that ACh might promote myogenesis 
(Entwistle et al., 1988; Krause et al., 1995), and that myotube survival might require 
neurotransmission (Sandri and Carraro, 1999). However, in analyzing the discrepancy 
between our results and the data on the ChAT-/- mouse line, it is worth noting that in 
vivo studies already presented different phenotypes of muscle fiber development and 
maturation between aneural and paralyzed muscles (Creazzo and Sohal, 1983; Sohal 
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and Holt, 1980). These studies suggested that in the absence of neurotransmission due 
to lack of presynaptic nerve terminals, myogenesis is severely impaired, and that in 
the last stages of embryonic development aneural muscles undergo massive cell death 
and disorganization. At the same time, paralyzed muscles displayed a milder 
phenotype in which the late stages of myogenesis were delayed and the number of 
muscle fibers was slightly reduced, but no cell death occurred and the existing muscle 
fibers had a normal appearance. These results are similar to those reported for the 
ChAT-/- mice in which neurotransmission is abolished (Misgeld et al., 2002) and in 
our results, respectively, suggesting that ACh might play a role in myotube survival 
and maturation, and that this role might be independent from AChR-mediated 
activity.  
 
 
7.1.7     Differences in Gene Expression 
 
Several additional questions during characterization of the γ/ε-fc mouse line required 
an analysis of mRNA transcript levels to be answered. One important point relates to 
the expression levels of the γ/ε-fc subunit, when compared to the expression of WT 
γ subunit. Another important question concerning the effects of an activity-impaired 
AChR during embryonic development is related to the possibility that absence of 
activity in muscle fibers expressing the γ/ε-fc subunit, or a very low expression level 
for the γ/ε-fc subunit, might lead to early expression of the ε subunit as a 
compensatory mechanism. Furthermore, it was important to collect additional data 
about the expression levels of other AChR subunits which could be affected by the 
presence of the mutated subunit, such as the α subunit, and the transcript levels for 
MuSK, which is known to be essential in initial synapse formation (DeChiara et al., 
1996) and maintenance, even in adult muscle (Hesser et al., 2006), and which could 
therefore be affected by the abnormal development of the γ/ε-fc NMJ.  
RT-PCR results at both E16 and E18 indicate that the expression levels of the the γ/ε-
fc subunit are about 30-40% of WT γ  subunit expression levels, suggesting that this 
is enough to synthesize and assemble a comparable amount of receptors as in the WT 
animal. The results also suggest that no overcompensation on the part of the ε subunit 
occurs when the functionality of the AChRγ is compromised and the activity of the 
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muscle fiber is impaired; this is consistent with similar observations related to lack of 
ε subunit overcompensation when γ subunit transcription and translation are 
extremely low (Yampolsky et al., 2008), and to complementary observations about 
the lack of stable overcompensation on the part of the γ subunit in mice whose ε 
subunit has been deleted (Witzemann et al., 1996), highlighting the two different 
roles played by AChRγ and AChRε during the animal’s life.  
Additionally, the expression levels of the α subunit are not significantly different 
from WT levels in γ/ε-fc embryos, suggesting that transcriptional regulation of the 
subunit does not depend on overall AChR activity nor on the transcriptional levels of 
other subunits, such as the γ/ε-fc subunit. Interestingly, expression levels for MuSK 
also appear to be unchanged between WT and γ/ε-fc embryos, confirming that 
transcription and activity of MuSK along the agrin pathway is not affected by the 
inactivity of the muscle fiber.  
 
 
7.1.8     Conclusions 
 
The role of the AChR during the embryonic development of the NMJ is a crucial 
point which needs to be elucidated in order to further our understanding of NMJ 
maturation and, by extension, of synapse formation. Thus far, however, knock-out 
mouse lines aimed at analyzing the effects of postsynaptic activity during embryonic 
development, such as the ChAT-/- mouse line (Misgeld et al., 2002) or the AChRγ-/- 
mouse line (Takahashi et al., 2002), could not properly distinguish between 
phenotypes caused by absence of postsynaptic transmission, and phenotypes caused 
by the disruption of additional molecular pathways due to the absence of crucial 
molecules such as ACh or the AChR itself.  
In this regard, the γ/ε-fc mouse line is an extremely refined tool to study the specific 
contribution of postsynaptic activity to the development of the NMJ, without 
disturbing additional pathways which do not depend upon receptor activity, due to the 
presence of a structurally intact AChR. Through the characterization of this mouse 
line and a comparison of its phenotype with the described phenotypes for other mouse 
lines with abolished synaptic transmission, it is possible to estimate the extent at 
which synaptic transmission is important for the proper development of the NMJ.  
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Such a comparison unavoidably leads to an interesting question. The phenotype 
described in animals with abolished synaptic transmission (ChAT-/-) is similar, but 
not identical, to the phenotype we describe here for the γ/ε-fc mouse line. Noteworthy 
differences present in the ChAT-/- animal include, but are not limited to an increase in 
endplate area at late embryonic stages that is almost four times the increase displayed 
in the γ/ε-fc embryos at the same age; the presence of a much thinner diaphragm 
leading to herniation of the liver; and extensive necrosis of muscle tissue. Previously, 
these phenotypes were thought to be also linked to synaptic transmission (Misgeld et 
al., 2002; Brandon et al., 2003), but their absence in the γ/ε-fc mouse line suggests 
that the picture might be more complex than it was once assumed.  
The complete AChR contains two binding sites for ACh (4.2.1): one is located 
between one α subunit and the δ subunit (αδ binding site) and the other is located 
between the second α subunit and the γ subunit (during embryonic development) or 
the ε subunit (during adult life) (αγ binding site). The transgenic γ/ε-fc subunit 
impairs the binding of ACh to the αγ binding site, and this has been shown to 
completely impair whole-cell currents of recombinant receptors expressed in 
heterologous systems (Peter et al., 2005; Ohno et al., 1996). ACh binding to the αδ 
binding site might, however, be unaffected or only affected to a lesser extent by the 
mutation. It is also known that the two binding sites have different properties, so that 
the same mutation in the δ subunit does not reduce the affinity of the αδ binding site 
for ACh as strongly, but still allows generation of electrical activity in the cell (Peter 
et al., 2005). Furthermore, gating studies have suggested that the two binding sites 
play different roles during the channel opening event, and that when both sites are 
bound to ACh, subunits participating in the αγ binding site move first, and are 
followed then by subunits participating in the αδ binding site (Mitra et al., 2005). 
Clinical studies have also strengthened the assertion of a difference in the activity of 
the two binding sites and the subunits they are composed of. Data from CMS patients 
suggest that mutations inducing significantly shorter channel-opening events when 
inserted in the AChRδ may have an opposite effect when inserted in the AChRε 
(Shen et al., 2002).  
If the two binding sites are not redundant, but have different functions to play, how 
could we correlate this assumption to the phenotypical differences we notice between 
animals in which synaptic transmission is completely abolished at both sites due to 
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lack of ACh (ChAT-/-) and animals in which synaptic transmission is abolished but 
both ACh and the WT αδ binding site are still present? Does the αδ binding site act 
as a modulator for channel-opening events which are triggered by the αγ binding site, 
and if that were true, would that be its only function? 
The E381K mutation, which is located in the long cytoplasmic loop of the δ subunit, 
was discovered in a German patient and characterized as the cause of a novel CMS 
(Müller et al., 2006). In vitro studies have demonstrated that this mutation in the δ 
subunit impairs the association of AChRs with rapsyn, but that if the same mutation is 
inserted in the ε subunit, it has no appreciable effect on rapsyn and AChR co-
clustering. It was then suggested that the δ subunit might play a special role in AChR-
rapsyn interactions. Taken together with the data about the different contributions of 
the αδ and αγ binding sites to AChR activity, such a hypothesis could suggest that 
some molecular events previously thought to be activity-dependent – such as rapsyn 
association and ACh-mediated dispersal of AChRs – could in fact depend on activity-
independent signaling on the part of AChR, perhaps through conformational changes 
of the receptor’s cytoplasmic region, and that this signaling would be mediated by the 
αδ binding site, with only minor contributions from the αγ binding site.  
Circumstantial evidence then suggests that the αδ binding site might play an 
important role apart from modulating synaptic transmission by correlating the 
description of this δ subunit-related CMS and its effects on the formation of synaptic 
clusters in vitro, to the differences between γ/ε-fc and ChAT-/- animals.  
This hypothesis could explain, for example, why the clustering of AChRs at late 
embryonic ages is much more pronounced in the ChAT-/- animals than in γ/ε-fc 
animals: conformational changes triggered by binding of ACh to the αδ binding site 
would not trigger channel opening, but might reduce the affinity of AChR for rapsyn, 
preventing rapsyn and AChR co-clustering and leading to the dispersal of these 
receptors. Because this pathway would not necessarily require activity or binding of 
ACh to the αγ binding site, the γ/ε-fc mouse line would not display a large increase in 
receptor clustering. In the absence of ACh, however, not only would activity be 
abolished, but lack of ACh binding at the αδ binding site would prevent rapsyn from 
disassociating, and lead to vastly increased clustering of AChRs. Several phenotypes 
could then be assigned to either the αδ or αγ binding site (Table 3) by comparing the 
γ/ε-fc to the ChAT-/- mouse lines.  
74 
 
The difference in the functionality of the two binding sites could also explain the 
decreased thickness of ChAT-/- diaphragms in comparison to γ/ε-fc diaphragms, and 
the presence of extensive muscle fiber necrosis which we have not observed in the 
γ/ε-fc mouse line.  
 
Table 3. Phenotypes and Putative Association to the Impairment of Different AChR 
Binding Sites. 
 
αγ binding site                   αδ binding site 
Triggers channel opening           Modulates channel opening 
No postsynaptic current         Reduced postsynaptic current 
Activity-dependent phenotypes        Conformation-dependent phenotypes 
Abnormal nerve growth           Increased AChR clustering (rapsyn binding?) 
Disruption of muscle fiber organization         Decreased number of muscle fibers? 
Presence of multiple endplates          Muscle fiber necrosis 
Flaccid paralysis, perinatal death              Impaired muscle fiber maturation 
Inactivity-induced muscular atrophy 
Inactivity-dependent motoneuron survival 
Increased width of central endplate band 
 
 
 
Until we acquire in-depth knowledge of the mechanisms of rapsyn binding to the 
AChR, which are still unknown, or a mouse model is created in which the αδ, but not 
the αγ binding site is functionally impaired, we can only speculate on whether the 
two binding sites of AChR could play such different roles during embryonic 
development. If this were the case, though, we could speculate that AChR sits at the 
center of two distinct pathways: an already described, molecular pathway in which 
AChR interacts with rapsyn through the δ subunit (Müller et al., 2006) and, through 
the action of dystroglycan and utrophin, with the muscle fiber cytoskeleton (Kummer 
et al., 2006); and an activity-dependent pathway in which AChR activity is 
responsible for retrograde signaling to the nerve terminal and plays a crucial role in 
the establishment of nerve architecture.  
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7.1.9     Further Projects Involving the γ/ε-fc Mouse Line 
 
The γ/ε-fc mouse line is an extremely powerful tool to study activity-dependent 
pathways in the development of the NMJ, and it has already offered interesting 
insights into the function of postsynaptic activity during embryonic life. An 
interesting question which we are currently addressing involves the possibility of 
rescuing γ/ε-fc newborns from perinatal death, and analyzing the presence or absence 
of long-lasting morphological differences in their diaphragms after the γ/ε switch has 
occurred. This will allow us to establish to which extent the morphological defects 
displayed during embryonic development are retained in postnatal life, and in 
particular whether muscle fiber organization defects, endplate anatomy, and the 
aberrant innervation pattern of γ/ε-fc animals can undergo plasticity and return to a 
WT-like situation, or if activity-related, embryonically acquired defects remain 
present throughout the animal’s life.  
Of further interest will also be the study of the activity threshold endplates need to 
reach in order for the animal to be viable, and exploiting a feature of the AChRγ-GFP 
line, we have begun studies of animals exhibiting strongly reduced presence of 
functional AChRs during embryonic development, coupled with the presence of a 
large majority of γ/ε-fc receptors, in order to study differences in the development of 
the NMJ between homozygous γ/ε-fc animals in which activity is abolished, and 
hemizygous animals in which activity is extremely reduced. 
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8. METHODS 
 
 
8.1     Animals 
 
Experiments were performed on γ/ε-fc animals derived from C57Bl/6 background. 
The animals were housed in the Interfakultäre Biomedizinische 
Forschungseinrichtung (IBF) in Heidelberg, fed ad libitum with commercial food 
pellets and chlorinated water. Temperature in the animal facility was maintained 
between 20-25°C with 55-65% humidity and a day-night cycle with 12-hour phases.  
 
 
8.1.1     Dissection and Preparation of Muscles 
 
In accordance with FELASA guidelines, female pregnant mice aged 2 to 12 months 
were anesthetized with CO2 and sacrificed through cervical dislocation. Embryos 
aged E16 and E18 were extracted from the uterus, sacrificed through decapitation, 
and dissected. Tails were removed for genotyping purposes. Extracted diaphragm 
muscles were held in Sylgard®-coated Petri dishes with insect needles and fixed with 
1% formaldehyde for 1h, then transferred into 24-well plates containing neural rat 
Ringer solution.  
Muscles from embryo upper hind legs were explanted and flash-frozen in liquid 
nitrogen to preserve RNA integrity, then stored at -80°C until RNA extraction.  
 
 
8.1.2     Preparation and Implantation of Osmotic Pumps 
 
ALZET mini-osmotic pumps (DURECT, CA, USA) model 2002 were filled with 200 
μl of a solution of 3,4-DAP (Sigma, St. Louis, MO, USA) in 0,9% saline, according 
to the manifacturer’s guidelines.  
Wild type female pregnant mice aged 2 to 6 months were anesthetized through 
intraperitoneal injection of anaesthetic mix (see below) and osmotic pumps were 
implanted subcutaneously according to manifacturer’s guidelines. Anesthesia was 
countered through subcutaneous injection of antidote mix (see below). 
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Anaesthetic Mix (1,1 ml/Kg, i.p.)
  22% Domitor® PfizerAH, Exton, PA, USA 
22% Dormicum® Roche, Basel, Switzerland 
56% Fentanyl® Ratiopharm, Ulm, Germany 
  
Antidote Mix (2,5 ml/Kg., s.c.) 
14% Antisedan® PfizerAH, Exton, PA, USA 
18% Naloxone® Ratiopharm, Ulm, Germany 
68% Anexate® Roche, Basel, Switzerland 
 
Blood was collected from mothers and embryos or newborn animals after one or two 
weeks of implantation. In accordance to FELASA guidelines, implanted and control 
animals were anesthetized with CO2 and sacrificed through cervical dislocation prior 
to blood collection. A minimum of 500 μl of blood was collected from each adult 
animal. Embryos and pups were killed through decapitation and the blood from each 
animal in the same litter was pooled together.  
Whole blood was centrifugated at 5°C, at a speed of 2.000 x g, for 30 min. Plasma 
was collected and sent for HPLC analysis performed by Labor Limbach (Heidelberg, 
Germany). Statistical analyses and graphical representations of data acquired from 
ImageJ were performed using the IgorPro software (WaveMetrics, Lake Oswego, 
OR, USA).  
 
 
8.2     Confocal Microscopy 
 
Confocal microscopy permits an increase in microphotograph contrast, the acquisition 
of high-resolution optical images, and the possibility to generate a projection or a 
three-dimensional reconstruction of a stack of images. 
Samples were analyzed using a Leica TCS NT (Leica Microsystems) microscope, 
using objectives with 10x, 20x, 40x and 63x magnification. An Argon-Krypton laser 
allowed fluorescence detection with wavelengths of 488 nm for green fluorescence, 
and 566 nm for red fluorescence. Fluorescence was enhanced through the use of a 
photomultiplier. Images were processed using Leica TCS NT software (Leica 
Microsystems) and ImageJ software (National Institute of Health, USA).   
For muscle fiber staining, samples were analyzed using a Leica SP2 microscope 
(Leica Microsystems) using objectives with 10x, 20x and 63x magnification. A 
Helium-Neon laser allowed fluorescence detection with wavelengths of 488 nm for 
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green fluorescence, and 566 nm for red fluorescence, while an UV laser allowed 
fluorescence detection with wavelengths of 354 nm for blue fluorescence. 
Fluorescence was enhanced through the use of a photomultiplier. Images were 
processed using Leica TCS SP2 software and Leica LAS AF Lite (Leica 
Microsystems), and ImageJ software (National Institute of Health, USA). 
 
 
8.2.1     Fluorescent Quantification 
 
Pictures of endplates from four different diaphragm regions and from three different 
animals per time point were taken at 63x magnification using confocal microscopy, 
with the same laser intensity but different green filter settings (30%, 50% and 80%). 
The pictures were opened using ImageJ software (NIH, USA) using standard plug-ins 
and a self-made automatized macro. Signal density in the green fluorescence was 
analyzed, and endplate density was assigned according to the comparison of endplate 
areas at different filter settings.  
Statistical analyses and graphical representations of data acquired from ImageJ were 
performed using the IgorPro software (WaveMetrics, Lake Oswego, OR, USA). The 
average standard deviation and standard error were calculated for each data set, and 
all trend lines were drawn taking into account the appropriate error bars.  
 
 
8.2.2     Area Measurement 
 
Pictures of endplates from four different diaphragm regions and from three different 
animals per time point were taken at 63x magnification using confocal microscopy, 
and opened using ImageJ software (NIH, USA) with standard plug-ins. 
Distinguishable endplates were selected and area measurements were collected both 
in pixels and in μm2.  
Statistical analyses and graphical representations of data acquired from ImageJ were 
performed using the IgorPro software (WaveMetrics, Lake Oswego, OR, USA). The 
average standard deviation and standard error were calculated for each data set, and 
all graphs were drawn taking into account the appropriate error bars.  
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8.2.3     Circularity Measurement 
 
Pictures of endplates from four different diaphragm regions and from three different 
animals per time point were taken at 63x magnification using confocal microscopy, 
and opened using ImageJ software (NIH, USA) with standard plug-ins. 
Distinguishable endplates were selected and circularity measurements were collected 
using standard ImageJ tools.  
Statistical analyses and graphical representations of data acquired from ImageJ were 
performed using the IgorPro software (WaveMetrics, Lake Oswego, OR, USA). The 
average standard deviation and standard error were calculated for each data set, and 
all graphs were drawn taking into account the appropriate error bars.  
 
 
8.2.4    Count of Endplates per Muscle Fiber 
 
Pictures of muscle fibers from three different diaphragm regions were taken at 63x 
magnification using confocal microscopy, and opened using ImageJ software (NIH, 
USA) with Volume Viewer plug-in (K. U. Barthel, Internationalen Medieninformatik, 
Berlin, Germany). 
Pseudo-3D reconstructions of each section were created through the Volume Viewer 
plug-in and each individual muscle fiber was traced from one end to the other. 
Stained endplates laying over the muscle fiber were analyzed optically.  
Statistical analyses and graphical representations of data acquired from ImageJ were 
performed using the IgorPro software (WaveMetrics, Lake Oswego, OR, USA). The 
average standard deviation and standard error were calculated for each data set, and 
all graphs were drawn taking into account the appropriate error bars.  
 
 
8.2.5    Analysis of Diaphragm Thickness and Muscle Fiber Diameter 
 
Pictures of muscle fibers from three different diaphragm regions were taken at 63x 
magnification using confocal microscopy, and opened using ImageJ software (NIH, 
USA) with Volume Viewer plug-in (K. U. Barthel, Internationalen Medieninformatik, 
Berlin, Germany). 
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Pseudo-3D reconstructions of each section were created through the Volume Viewer 
plug-in, and the thickness of each diaphragm section was analyzed by tracing. The 
minor and major diameter of each individual muscle fiber was traced at three 
different locations along the muscle fiber. The area of the fiber cross-section in the 
three different locations was calculated and the diameter of a circle with equivalent 
area was extracted in order to normalize the results.  
Statistical analyses and graphical representations of data acquired from ImageJ were 
performed using the IgorPro software (WaveMetrics, Lake Oswego, OR, USA). The 
average standard deviation and standard error were calculated for each data set, and 
all graphs were drawn taking into account the appropriate error bars.  
 
 
8.3     Molecular Biology Methods 
 
8.3.1    Standard Molecular Biology Methods 
 
Standard molecular biology methods, such as DNA cutting via restriction 
endonucleases, dephosphorylation of DNA endings, DNA ligation and DNA gel 
electrophoresis, used standard protocols from the Maniatis laboratory book (Maniatis 
et al., 1987). These methods are not described below.  
 
 
8.3.2    Genotyping of Specimens 
 
Genotyping of the specimens via PCR analysis was used to identify wild-type and 
homozygous embryos.  
Extraction of genomic DNA from embryo tails was performed using Qiagen QIAamp 
DNA Mini Kit (Qiagen, Hilden, Germany). The final concentration of genomic DNA 
was not determined, and a fixed volume was used for PCR. 
The analysis of transgenic embryos required two separate PCR reactions, one to 
detect the presence of the wild-type AChRγ gene and one to detect the presence of the 
γ/ε-fc transgene. The reverse primer for the identification of the γ/ε-fc transgene was 
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generated from a targeting vector sequence which is not present in the genomic 
sequence. Primers were obtained from MWG Biotech (Ebersberg, Germany).  
PCR samples were analyzed by loading 20 μl on a 1% agarose gel and performing 
DNA gel electrophoresis. 
 
PCR Mix 
0,5 μl genomic DNA 
5 μl 10x HotStar Taq Buffer (Qiagen, Hilden, Germany) 
1 μl 5’ Primer (125 ng/μl) 
1 μl 3’ Primer (125 ng/μl) 
8 μl dNTP (1,25 mM each) 
0,5 μl HotStar Taq Polymerase (Qiagen, Hilden, Germany) 
to 50 μl ddH2O 
 
γ/ε-fc Genotyping Program 
15 min   95°C 
45 s   94°C 
45 s   60°C       32x 
1 min 30 s  72°C 
10 min   72°C 
 
 
8.3.3    Isolation of RNA from Muscle Tissue 
 
RNA was isolated from embryo upper hind leg muscles according to the TRIzol 
protocol (Invitrogen, Carlsbad, CA, USA). Frozen muscles were homogenized in 2 
ml TRIzol reagent using an Ultra-Turax T18 Polytron (IKA) power homogenizer. The 
isolation of RNA followed the standard protocol, with the addition of a centrifugation 
step at 12.000 x g for 10 minutes at 4°C in order to remove tissue remains. After 
drying, RNA was resuspended in 100 μl DEPC-H2O, its concentration was assayed 
via optical density measurement, and the probes were then stored at -20°C. 
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8.3.4    Reverse Transcription 
 
5 μg of RNA isolated from muscle tissue were purified of DNA remains through 
“DNA-free” kits (Ambion, Austin, TX, USA). The volume was brought to 50 μl, then 
1/10 volume (5 μl) Na-Acetate and 2 ½ volumes (125 μl) of abs. ethanol were added. 
Samples were precipitated at -20°C for 10 minutes, then pelleted via centrifugation at 
13.000 x g for 10 minutes at RT, on a desktop centrifuge. The pellet was then 
resuspended in 10 μl H2O at 68°C. 
The RNA solution was mixed with the Reverse Transcription mix, 1 μl of 
SuperScript II reverse transcriptase (200 U/μl; Invitrogen, Carlsbad, CA, USA) was 
added, and the sample was incubated at 37°C for 1 hour. Afterwards, the transcriptase 
was inactivated at 95°C for 5 minutes.  
 
Reverse Transcription Mix 
4 μl 5x RT Buffer (Invitrogen) 
2 μl 0,1 M DTT 
1 μl RNA Guard (Invitrogen) 
1 μl dNTPs 
8 μl pd(N6) Primer 
 +1 μl SuperScript II Reverse 
Transcriptase (200 U/μl; 
Invitrogen) 
+10 μl RNA Solution (0,5 μg/μl) 
 
 
8.3.5    Real-Time PCR 
 
TaqMan Assay-on-Demand Expression Products (Applied Biosystems, Darmstadt) 
and the standard primers within were used for Real-Time PCR. Three repetitions 
were performed for each PCR reaction. The housekeeping gene glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) was used as a cellular control.  
 
 
 
1 hour at 37°C 
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Real-Time PCR Mix 
8,75 μl ddH2O 
12,5 μl TaqMan Universal PCR Master Mix 
1,25 μl 20x Assay-on-Demand Gene 
Expression Mix 
2,5 μl cDNA (125 μg/ml) 
 
Real-Time PCR Program 
95°C   10 min 
95°C  15 s 
60°C  40 s 
 
An ABS 7500 RealTime System (Applied Biosystems, USA) was used for the Real-
Time PCR reaction. Analysis was performed with help from 7500 System SDS 
Software (Applied Biosystems, USA) following the method for relative ΔΔCt 
quantification (Livak and Schmittgen, 2001). The expression of GAPDH (Assay 
Mm99999915_g1) was used as an internal control.  
 
Tissue samples from three different animals for each time point were collected. Each 
probe was analyzed in triplets and the analysis was repeated twice, to exclude 
pipetting errors. IgorPro Software (WaveMetrics, Lake Oswego, OR) was used for 
statistical analysis of the data. The average standard deviation was calculated for each 
data series, and error bars were applied to all trend lines. Since the expression of 
GAPDH during development is relatively stable (Mamo et al., 2007), the transcripts 
measured quantities as percentages of GAPDH expression. Relative quantification 
allows for experimental comparison of the expression levels of different genes, 
therefore not offering absolute gene expression data, but a trend of expression levels 
during development.  
 
 
 
 
 
 
45 cycles 
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8.4     Histological Methods 
 
8.4.1    Antibody – α-Bungarotoxin Staining 
 
Antibody staining of the diaphragm using anti-neurofilament antibodies and 
bungarotoxin allows simultaneous detection of nerve fibers and neuromuscular 
synapses through confocal microscopy. In conjunction with anti-muscle fiber 
staining, it is possible to detect the organization of muscle fibers and aberrations in 
the synaptic organization of individual fibers.  
Diaphragms which had previously been treated with formadehyde for fixation (see 
8.1.1) were incubated overnight at 4°C with 0,1M Glycine/PBS. Afterwards, 
diaphragms were permeabilised with 1% Triton/PBS at RT for 3 h, and incubated 
overnight with primary antibody diluted in 2% BSA/PBS. Diaphragms were then 
washed with PBS and incubated overnight with secondary antibody in a 2% solution 
of BSA/PBS containing α-bgtx to enhance AChR fluorescence. Finally, diaphragms 
were washed with 2% BSA/PBS, mounted on glass slide with Citifluor (Agar 
Scientific, Stansted, England), and analyzed through confocal microscopy.  
 
 
 
 
8.4.2    Acetylcholinesterase Staining and Endplate Distribution 
 
AChE staining allows visualization and counting of the neuromuscular junctions in a 
light microscope. The staining was based on the Koelle and Friedenwald method 
(1949). 
The diaphragm was incubated for 90 min in the staining solution, and washed with 
H2O afterwards. After incubation with 5 mM potassium ferrocyanide for 30 min, 
synapses were stained brown. The diaphragm was washed with PBS before being 
mounted on a glass slide and analyzed at the microscope.  
 Type, Target Dilution 
Primary Antibodies 
mouse, slow skeletal myosin 1:5000 
rabbit, α-neurofilament 1:500 
rabbit, synaptophysin 1:50 
Secondary Antibodies AMCA-labeled α-mouse goat IgG 1.100 
rhodamine-labeled α-rabbit goat IgG 1:100 
Toxins FITC-labeled α-bgtx (1 mg/ml) 1:500 
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Acetate Buffer  Staining Solution (fresh)
150 mM CH3COOH  9 ml     acetate buffer
350 mM CH3COO-Na  30 mg  acetylthiocholine iodide 
  1 ml     glycine – copper sulphate solution 
Glycine – Copper Sulphate Solution   
500 mM Glycine   
100 mM CuSO4   
 
Pictures from sternal and lumbar sections of WT and homozygous diaphragms (2 
animals per experiment) were taken using a Zeiss Axioplan2 microscope (Carl Zeiss 
Inc.) through conventional light microscopy, and analyzed using ImageJ software 
(NIH, USA) with standard plug-ins. Three lines were drawn from the inner to the 
outer edge of each region of the diaphragm and the distance of the first and last 
endplate on the line was measured from the inner edge of the diaphragm. Data were 
analyzed in IgorPro (WaveMetrics, Lake Oswego, OR, USA). Data were analyzed 
separately for each region, and an analysis of the overall hemidiaphragm was also 
performed. Individual percentages were generated based on the width of diaphragm 
for each analyzed line. The average standard deviation was calculated for each data 
set. Student’s t tests were performed for statistical analysis. A probability value ≤0,05 
was taken as criterion for statistical significance.  
 
 
8.4.3    Paraffin Embedding of Tissue Samples 
 
Mouse embryos were killed by decapitation. The animal was dissected to collect the 
torso, from the lower cervical to the upper thoracic segments of the spinal cord. The 
tissue was treated with a mild zinc fixative (0,05% calcium acetate, 0,5% zinc acetate, 
0,5% zinc chloride, in 0,1 M Tris Buffer pH 7.4) for fixation at RT, over a period of 4 
days, replacing the fixative daily. The tissue was embedded in paraffin and cut in a 
paraffin microtome (Zeiss) into sections 7 μm thick. The cut sections were stretched 
in a water bath at 42°C for 5 min, and then collected on a microscope slide and dried 
on a heated plate for 30 min at 45°C. The samples were stored at RT until staining.  
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8.4.4    Choline Acetyltransferase Staining of Paraffin Sections 
 
ChAT staining allows visualization and quantification of motor neurons in the lateral 
motor column of the spinal cord.  
Every fifth section taken in the region of the lateral motor column (LMC) of paraffin-
embedded samples between the cervical vertebra C5 and the thoracic vertebra T1 was 
treated with choline acetyltransferase antibodies (α-ChAT, Chemicon). Paraffin was 
removed by treating sections with xylol, the sections were then rehydrated through an 
EtOH scale (100%, 96% and 70%, 2 minutes each) and then washed in PBS. The 
immunohistochemical staining with α-ChAT was performed according to the 
following protocol:  
  
- Incubation in 1% H2O2 in ddH2O for 20 min at RT 
- Blocking with 5% BSA + 1% TritonX in PBS for 2 h 
- Removal of the blocking solution, no washing 
- Incubation with ChAT antibodies at 4°C o.n., diluted 1:500 in 1% BSA + 
0,4% TritonX in PBS 
- Washing 5x 5 minutes with PBS 
- Incubation with biotinylated anti-goat secondary antibody (BA-9500, 
Vectorlabs) for 2 h at RT; dilution 1:200 in 1% BSA + 0,4% TritonX in 
PBS 
- Washing in PBS for 5 min 
 
The subsequent colorimetric quantification was performed with the help of the ABC-
Elite kit (Vectorlabs) as per the manifacturer’s specifications. The sections were 
counterstained with eosin, dehydrated in an ethanol scale, clarified with Neo-Clear®  
(Merck) and mounted with Neo-Mount® (Merck). Pictures were taken using a Zeiss 
Axioplan2 microscope (Carl Zeiss Inc.) through conventional light microscopy, and 
analyzed using ImageJ software (NIH, USA) with Cell Counter plug-in (K. De Vos, 
University of Sheffield, UK). The resulting data were analyzed in IgorPro 
(WaveMetrics, Lake Oswego, OR, USA). 
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8.4.5    Analysis of Motor Neuron Length 
 
The innervation pattern of the diaphragm was analyzed using anti-neurofilament 
antibody staining. Hemidiaphragm composite images were opened with ImageJ (NIH, 
USA) using the NeuronJ plug-in (E. Meijering, Erasmus MC – University Medical 
Center Rotterdam, Netherlands). Each secondary neurite was traced starting with the 
primary branching away from the nervus phrenicus and up to its distal end. Data were 
analyzed in IgorPro (WaveMetrics, Lake Oswego, OR, USA). Neurites were grouped 
according to their absolute length, and according to their length relative to the 
appropriate primary neurite. Percentages were generated based on total neurite 
number. The average standard deviation was calculated for each data set. Student’s t 
tests were performed for statistical analysis. A probability value ≤0,05 was taken as 
criterion for statistical significance.  
For cumulative probability distributions, Kolmogorov-Smirnov tests were performed 
for statistical analysis. A probability value ≤0,05 was taken as criterion for statistical 
significance. 
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9. MATERIALS 
 
 
9.1     Chemicals 
 
Chemical substances used in this work were purchased from the following companies:  
 
Aldrich, Steinheim, Germany 
Amersham, Braunschweig, Germany 
Biomol, Hamburg, Germany 
Bio-Rad, Munich, Germany 
Biozym, Hameln, Germany 
Fluka, Neu-Ulm, Germany 
GERBU, Gaiberg, Germany 
Gibco BRL, Eggenstein, Germany 
IBI, New Haven, CT, USA 
MBI Fermentas, Wilna, Lithuania 
Merck, Darmstadt, Germany 
 
 
Pharmacia Biotech, Freiburg, Germany 
PfizerAH, Exton, PA, USA 
Ratiopharm, Ulm, Germany 
Riedel, Seelze, Germany 
Roche, Basel, Switzerland 
Roth GmbH, Darmstadt, Germany 
Sakura, Zoeterwoude, Germany 
Serva, Heidelberg, Germany 
Sigma, St. Louis, MO, USA 
Vector Laboratories, Burlingame, CA, USA 
 
 
9.2     Enzymes 
 
9.2.1     General Enzymes 
 
DNAse I (5 U/μl)     Ambion (Austin, TX, USA) 
Proteinase K (20 mg/ml)    Roche (Mannheim, DE) 
RNAse A (10 mg/ml)     Roche (Mannheim, DE) 
SuperScript II Reverse Transcriptase (200 U/μl) Invitrogen (Carlsbad, CA, USA) 
 
 
9.2.2     Polymerases 
 
Hot Star Taq Polymerase    Qiagen (Hilden, DE) 
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9.3     Primers, Oligonucleotides and Probes 
 
Primers and oligonucleotides used in this work were synthetized by MWG-Biotech 
(Ebersberg, Germany). “TaqMan Assays-on-Demand” for quantitative Real-Time PCR 
were purchased from Applied Biosystems (Darmstadt, Germany).  
 
All sequences are oriented starting from the 5’ end.  
 
Genotyping Primers 
 WT AChRγ 
mg 187F 5’ (forward) 5’-GAT GCG AAA CTA CGA CCC C-3’ 
mg 536R 3’ (reverse) 5’-AGG AGG AGC GGA AGA TGG-3’ 
 
 γ/ε-fc 
mg 187F 5’ (forward) 5’-GAT GCG AAA CTA CGA CCC C-3’ 
mg 785R 3’ (reverse) 5’-CAG AAA TGA GCA CGC AAG G-3’ 
 
 
9.4     Kits 
 
ABC-Elite Kit      Vector Labs (Burlingame, CA, USA) 
DNA-Free Kit      Ambion (Austin, TX, USA) 
QIAAmp DNA Mini Kit    Qiagen (Hilden, DE) 
 
 
9.5     DNA Ladders 
 
Lambda DNA/EcoRI+HindIII Marker 3  MBI Fermentas (Vilnius, Lithuania) 
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9.6     Buffers, Solutions and Media 
 
Citifluor       Agar Scientific (Stansted, England) 
Neo-Clear      Merck (Darmstadt, Germany) 
Neo-Mount      Merck (Darmstadt, Germany) 
PBS       Gibco/Invitrogen (Carlsbad, CA, USA) 
RT 5x Buffer      Invitrogen (Carlsbad, CA, USA) 
 
 
9.7     Antibodies 
 
α-Cholinacetyltransferase (goat)   Chemicon (Temecula, CA, USA) 
α-Neurofilament (rabbit)    Chemicon (Temecula, CA, USA) 
α-Slow skeletal myosin (mouse)   Sigma (St. Louis, MO, USA) 
α-Synaptophysin (rabbit)    Zymed (San Francisco, CA, USA) 
AMCA-conjugated goat α-mouse IgG  Molecular Probes (Eugene, CA, USA) 
Biotin-conjugated horse α-goat IgG   Vector Labs (Burlingame, CA, USA) 
Rhodamine-conjugated goat α-rabbit IgG  Molecular Probes (Eugene, CA, USA) 
 
 
9.8     PCR and Real-Time PCR Reagents 
 
HotStar Taq 10x Buffer    Qiagen (Hilden, DE) 
dNTPs       Pharmacia (Erlangen, DE) 
TaqMan Universal PCR Master Mix   Applied Biosystems (Darmstadt, DE) 
 
 
9.9     Mouse Lines 
 
C57 Bl/6J      RCC/BRL (Basel, Switzerland) 
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9.10     Miscellaneous Items 
 
ALZET Mini-Osmotic Pumps 2002   Durect, CA, USA 
Mounting glass slides: “Super Frost Plus”  Roth (Darmstadt, DE) 
Razor Blade Holder     Dumont (Montignez, Switzerland) 
Razor Blades      F.S.T. (Heidelberg, DE) 
Tools for Tissue Preparation    Dumont (Montignez, Switzerland) 
Tweezers      Dumont (Montignez, Switzerland) 
 
 
9.11     Miscellaneous Equipment 
 
Confocal Microscope – “TCS NT”   Leica (Heidelberg, DE) 
Desktop Centrifuge – “Biofuge 13”   Heraeus (Waltham, MA, USA) 
Fluorescence Microscope – “Axioplan 2”  Zeiss (Oberkochen, DE) 
Light Microscope – “Axioplan 2”   Zeiss (Oberkochen, DE) 
Microscope Camera – “3CCD Seescan”  Intas (Göttingen, DE) 
Objectives – “Neofluar” (2,5x; 5x; 40x; 63x)  Zeiss (Oberkochen, DE) 
Paraffin Microtome RM2145    Leica (Heidelberg, DE) 
PCR Thermocycler – “T-Gradient”   Biometra (Göttingen, DE) 
Polytron T18      Kinematic (Littau, Switzerland) 
Spectral Photometer – “Heliosβ”   Unicam (Waltham, MA, USA) 
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